<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035569</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035569">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035569</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>1 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td>
                                None
                            </td></tr><tr><th>
                        Size:
                    </th><td>174 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 2 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>15&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Accept-Ranges: bytes<br>Age: 0<br>Alt-Svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000<br>Cache-Control: no-cache, no-store, max-age=0, must-revalidate<br>Content-Language: en-US<br>Date: Wed, 27 Sep 2023 21:57:04 GMT<br>Pragma: no-cache<br>Server: Apache<br>Strict-Transport-Security: max-age=31536000 ; includeSubDomains<br>Transfer-Encoding: chunked<br>Via: 1.1 varnish (Varnish/6.0), 1.1 google<br>X-Content-Type-Options: nosniff<br>X-Frame-Options: DENY<br>X-Varnish: 885033631<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://content.montefioreeinstein.org/cancer/research/cdtmi/cdtmi-research" data-pageid="6651" data-line="0" data-col="0">https://content.montefioreeinstein.org/cancer/research/cdtmi/cdtmi-research</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>          </code></p><p><code>2</code><code>&lt;!DOCTYPE html&gt;</code></p><p><code>3</code><code>&lt;html xmlns="http://www.w3.org/1999/xhtml"</code></p><p><code>4</code><code>      xmlns:dc="http://purl.org/dc/terms/"</code></p><p><code>5</code><code>      xmlns:doi="http://dx.doi.org/"</code></p><p><code>6</code><code>      lang="en" xml:lang="en"</code></p><p><code>7</code><code>      itemscope itemtype="http://schema.org/Article"</code></p><p><code>8</code><code>      class="no-js"&gt;</code></p><p><code>9</code><code>          </code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>          </code></p><p><code>12</code><code>&lt;head prefix="og: http://ogp.me/ns#"&gt;</code></p><p><code>13</code><code>          </code></p><p><code>14</code><code>          </code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>          </code></p><p><code>17</code><code>&lt;link rel="stylesheet" href="/resource/css/screen.css?c2768a821a1cf36c1b50bb0a14fe8824"/&gt;</code></p><p><code>18</code><code>  &lt;!-- allows for  extra head tags --&gt;</code></p><p><code>19</code><code>          </code></p><p><code>20</code><code>          </code></p><p><code>21</code><code>&lt;!-- hello --&gt;</code></p><p><code>22</code><code>&lt;link rel="stylesheet" type="text/css"</code></p><p><code>23</code><code>      href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,600"&gt;</code></p><p><code>24</code><code>          </code></p><p><code>25</code><code>&lt;link media="print" rel="stylesheet" type="text/css"  href="/resource/css/print.css"/&gt;</code></p><p><code>26</code><code>    &lt;script type="text/javascript"&gt;</code></p><p><code>27</code><code>        var siteUrlPrefix = "/plosone/";</code></p><p><code>28</code><code>    &lt;/script&gt;</code></p><p><code>29</code><code>  &lt;script src="/resource/js/vendor/modernizr-v2.7.1.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>30</code><code>  &lt;script src="/resource/js/vendor/detectizr.min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>31</code><code>          </code></p><p><code>32</code><code>  &lt;link rel="shortcut icon" href="/resource/img/favicon.ico" type="image/x-icon"/&gt;</code></p><p><code>33</code><code>  &lt;meta http-equiv="Content-Type" content="text/html; charset=utf-8"/&gt;</code></p><p><code>34</code><code>          </code></p><p><code>35</code><code>          </code></p><p><code>36</code><code>          </code></p><p><code>37</code><code>          </code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>          </code></p><p><code>40</code><code>  &lt;link rel="canonical" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035569" /&gt;</code></p><p><code>41</code><code>  &lt;meta name="description" content="Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P&amp;lt;0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p&amp;lt;0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines." /&gt;</code></p><p><code>42</code><code>          </code></p><p><code>43</code><code>  &lt;meta name="citation_abstract" content="Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P&amp;lt;0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p&amp;lt;0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines."&gt;</code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>          </code></p><p><code>46</code><code>  &lt;meta name="keywords" content="Breast cancer,Cancer treatment,Metastasis,Small interfering RNA,Fats,Cancers and neoplasms,Gene expression,Metastatic tumors" /&gt;</code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>          </code></p><p><code>49</code><code>&lt;meta name="citation_doi" content="10.1371/journal.pone.0035569"/&gt;</code></p><p><code>50</code><code>&lt;meta name="citation_author" content="Ryung S. Kim"/&gt;</code></p><p><code>51</code><code>  &lt;meta name="citation_author_institution" content="Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, United States of America"/&gt;</code></p><p><code>52</code><code>&lt;meta name="citation_author" content="Alvaro Avivar-Valderas"/&gt;</code></p><p><code>53</code><code>  &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America"/&gt;</code></p><p><code>54</code><code>&lt;meta name="citation_author" content="Yeriel Estrada"/&gt;</code></p><p><code>55</code><code>  &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America"/&gt;</code></p><p><code>56</code><code>&lt;meta name="citation_author" content="Paloma Bragado"/&gt;</code></p><p><code>57</code><code>  &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America"/&gt;</code></p><p><code>58</code><code>&lt;meta name="citation_author" content="Maria Soledad Sosa"/&gt;</code></p><p><code>59</code><code>  &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America"/&gt;</code></p><p><code>60</code><code>&lt;meta name="citation_author" content="Julio A. Aguirre-Ghiso"/&gt;</code></p><p><code>61</code><code>  &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America"/&gt;</code></p><p><code>62</code><code>&lt;meta name="citation_author" content="Jeffrey E. Segall"/&gt;</code></p><p><code>63</code><code>  &lt;meta name="citation_author_institution" content="Department of Anatomy and Structural Biology and the Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, United States of America"/&gt;</code></p><p><code>64</code><code>          </code></p><p><code>65</code><code>&lt;meta name="citation_title" content="Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer"/&gt;</code></p><p><code>66</code><code>&lt;meta itemprop="name" content="Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer"/&gt;</code></p><p><code>67</code><code>&lt;meta name="citation_journal_title" content="PLOS ONE"/&gt;</code></p><p><code>68</code><code>&lt;meta name="citation_journal_abbrev" content="PLOS ONE"/&gt;</code></p><p><code>69</code><code>&lt;meta name="citation_date" content="Apr 18, 2012"/&gt;</code></p><p><code>70</code><code>&lt;meta name="citation_firstpage" content="e35569"/&gt;</code></p><p><code>71</code><code>&lt;meta name="citation_issue" content="4"/&gt;</code></p><p><code>72</code><code>&lt;meta name="citation_volume" content="7"/&gt;</code></p><p><code>73</code><code>&lt;meta name="citation_issn" content="1932-6203"/&gt;</code></p><p><code>74</code><code>&lt;meta name="citation_publisher" content="Public Library of Science"/&gt;</code></p><p><code>75</code><code>          </code></p><p><code>76</code><code>  &lt;meta name="citation_pdf_url" content="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0035569&amp;type=printable"&gt;</code></p><p><code>77</code><code>          </code></p><p><code>78</code><code>  &lt;meta name="citation_article_type" content="Research Article"&gt;</code></p><p><code>79</code><code>          </code></p><p><code>80</code><code>&lt;meta name="dc.identifier" content="10.1371/journal.pone.0035569" /&gt;</code></p><p><code>81</code><code>          </code></p><p><code>82</code><code>          </code></p><p><code>83</code><code>  &lt;meta name="twitter:card" content="summary" /&gt;</code></p><p><code>84</code><code>  &lt;meta name="twitter:site" content="plosone"/&gt;</code></p><p><code>85</code><code>    &lt;meta name="twitter:title" content="Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer" /&gt;</code></p><p><code>86</code><code>    &lt;meta property="twitter:description" content="Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P&amp;lt;0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p&amp;lt;0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines." /&gt;</code></p><p><code>87</code><code>    &lt;meta property="twitter:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0035569.g003&amp;size=inline" /&gt;</code></p><p><code>88</code><code>          </code></p><p><code>89</code><code>&lt;meta property="og:type" content="article" /&gt;</code></p><p><code>90</code><code>&lt;meta property="og:url" content="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035569"/&gt;</code></p><p><code>91</code><code>&lt;meta property="og:title" content="Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer"/&gt;</code></p><p><code>92</code><code>&lt;meta property="og:description" content="Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P&amp;lt;0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p&amp;lt;0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased in vivo growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines."/&gt;</code></p><p><code>93</code><code>&lt;meta property="og:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0035569.g003&amp;size=inline"/&gt;</code></p><p><code>94</code><code>          </code></p><p><code>95</code><code>&lt;meta name="citation_reference" content="citation_title=Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.;citation_author=GN Naumov;citation_author=JL Townson;citation_author=IC MacDonald;citation_author=SM Wilson;citation_author=VH Bramwell;citation_journal_title=Breast Cancer Res Treat;citation_volume=82;citation_number=82;citation_first_page=199;citation_last_page=206;citation_publication_date=2003;"/&gt;    </code></p><p><code>96</code><code>&lt;meta name="citation_reference" content="citation_title=Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.;citation_author=V Muller;citation_author=N Stahmann;citation_author=S Riethdorf;citation_author=T Rau;citation_author=T Zabel;citation_journal_title=Clin Cancer Res;citation_volume=11;citation_number=11;citation_first_page=3678;citation_last_page=3685;citation_publication_date=2005;"/&gt;    </code></p><p><code>97</code><code>&lt;meta name="citation_reference" content="citation_title=Dissecting the metastatic cascade.;citation_author=K Pantel;citation_author=RH Brakenhoff;citation_journal_title=Nat Rev Cancer;citation_volume=4;citation_number=4;citation_first_page=448;citation_last_page=456;citation_publication_date=2004;"/&gt;    </code></p><p><code>98</code><code>&lt;meta name="citation_reference" content="citation_title=Models, mechanisms and clinical evidence for cancer dormancy.;citation_author=JA Aguirre-Ghiso;citation_journal_title=Nat Rev Cancer;citation_volume=7;citation_number=7;citation_first_page=834;citation_last_page=846;citation_publication_date=2007;"/&gt;    </code></p><p><code>99</code><code>&lt;meta name="citation_reference" content="citation_title=Tumor Cell Dormancy: An NCI Workshop Report.;citation_author=RL Vessella;citation_author=K Pantel;citation_author=S Mohla;citation_journal_title=Cancer Biol Ther;citation_volume=6;citation_number=6;citation_publication_date=2007;"/&gt;    </code></p><p><code>100</code><code>&lt;meta name="citation_reference" content="citation_title=Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence.;citation_author=AP Adam;citation_author=A George;citation_author=D Schewe;citation_author=P Bragado;citation_author=BV Iglesias;citation_journal_title=Cancer Res;citation_volume=69;citation_number=69;citation_first_page=5664;citation_last_page=5672;citation_publication_date=2009;"/&gt;    </code></p><p><code>101</code><code>&lt;meta name="citation_reference" content="citation_title=Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.;citation_author=N Almog;citation_author=L Ma;citation_author=R Raychowdhury;citation_author=C Schwager;citation_author=R Erber;citation_journal_title=Cancer Res;citation_volume=69;citation_number=69;citation_first_page=836;citation_last_page=844;citation_publication_date=2009;"/&gt;    </code></p><p><code>102</code><code>&lt;meta name="citation_reference" content="citation_title=A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.;citation_author=RM Neve;citation_author=K Chin;citation_author=J Fridlyand;citation_author=J Yeh;citation_author=FL Baehner;citation_journal_title=Cancer Cell;citation_volume=10;citation_number=10;citation_first_page=515;citation_last_page=527;citation_publication_date=2006;"/&gt;    </code></p><p><code>103</code><code>&lt;meta name="citation_reference" content="citation_title=The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.;citation_author=PA Kenny;citation_author=GY Lee;citation_author=CA Myers;citation_author=RM Neve;citation_author=JR Semeiks;citation_journal_title=Mol Oncol;citation_volume=1;citation_number=1;citation_first_page=84;citation_last_page=96;citation_publication_date=2007;"/&gt;    </code></p><p><code>104</code><code>&lt;meta name="citation_reference" content="citation_title=Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.;citation_author=S Loi;citation_author=B Haibe-Kains;citation_author=C Desmedt;citation_author=F Lallemand;citation_author=AM Tutt;citation_journal_title=J Clin Oncol;citation_volume=25;citation_number=25;citation_first_page=1239;citation_last_page=1246;citation_publication_date=2007;"/&gt;    </code></p><p><code>105</code><code>&lt;meta name="citation_reference" content="citation_title=Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.;citation_author=Y Wang;citation_author=JG Klijn;citation_author=Y Zhang;citation_author=AM Sieuwerts;citation_author=MP Look;citation_journal_title=Lancet;citation_volume=365;citation_number=365;citation_first_page=671;citation_last_page=679;citation_publication_date=2005;"/&gt;    </code></p><p><code>106</code><code>&lt;meta name="citation_reference" content="citation_title=Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.;citation_author=Y Pawitan;citation_author=J Bjohle;citation_author=L Amler;citation_author=AL Borg;citation_author=S Egyhazi;citation_journal_title=Breast Cancer Res;citation_volume=7;citation_number=7;citation_first_page=R953;citation_last_page=964;citation_publication_date=2005;"/&gt;    </code></p><p><code>107</code><code>&lt;meta name="citation_reference" content="citation_title=A gene-expression signature as a predictor of survival in breast cancer.;citation_author=MJ van de Vijver;citation_author=YD He;citation_author=LJ van't Veer;citation_author=H Dai;citation_author=AA Hart;citation_journal_title=N Engl J Med;citation_volume=347;citation_number=347;citation_first_page=1999;citation_last_page=2009;citation_publication_date=2002;"/&gt;    </code></p><p><code>108</code><code>&lt;meta name="citation_reference" content="citation_title=Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.;citation_author=AH Klopp;citation_author=L Lacerda;citation_author=A Gupta;citation_author=BG Debeb;citation_author=T Solley;citation_journal_title=PLoS One;citation_volume=5;citation_number=5;citation_first_page=e12180;citation_publication_date=2010;"/&gt;    </code></p><p><code>109</code><code>&lt;meta name="citation_reference" content="citation_title=Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.;citation_journal_title=Lancet;citation_volume=365;citation_number=365;citation_first_page=1687;citation_last_page=1717;citation_publication_date=2005;"/&gt;    </code></p><p><code>110</code><code>&lt;meta name="citation_reference" content="citation_title=Luminal-B breast cancer and novel therapeutic targets.;citation_author=B Tran;citation_author=PL Bedard;citation_journal_title=Breast Cancer Res;citation_volume=13;citation_number=13;citation_first_page=221;citation_publication_date=2011;"/&gt;    </code></p><p><code>111</code><code>&lt;meta name="citation_reference" content="citation_title=Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta.;citation_author=M Takekawa;citation_author=K Tatebayashi;citation_author=F Itoh;citation_author=M Adachi;citation_author=K Imai;citation_journal_title=Embo J;citation_volume=21;citation_number=21;citation_first_page=6473;citation_last_page=6482;citation_publication_date=2002;"/&gt;    </code></p><p><code>112</code><code>&lt;meta name="citation_reference" content="citation_title=TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.;citation_author=FC McGillicuddy;citation_author=D O'Toole;citation_author=JA Hickey;citation_author=WM Gallagher;citation_author=KA Dawson;citation_journal_title=Vascul Pharmacol;citation_volume=44;citation_number=44;citation_first_page=469;citation_last_page=475;citation_publication_date=2006;"/&gt;    </code></p><p><code>113</code><code>&lt;meta name="citation_reference" content="citation_title=A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.;citation_author=M Adorno;citation_author=M Cordenonsi;citation_author=M Montagner;citation_author=S Dupont;citation_author=C Wong;citation_journal_title=Cell;citation_volume=137;citation_number=137;citation_first_page=87;citation_last_page=98;citation_publication_date=2009;"/&gt;    </code></p><p><code>114</code><code>&lt;meta name="citation_reference" content="citation_title=DNA-Chip Analyzer (dChip).;citation_author=C Li;citation_author=WH Wong;citation_first_page=120;citation_last_page=141;citation_publication_date=2003;citation_publisher=Springer"/&gt;    </code></p><p><code>115</code><code>&lt;meta name="citation_reference" content="citation_title=Nonparametric Statistical Methods;citation_author=MW Hollander;citation_author=A Douglas;citation_publication_date=1973;citation_publisher=John Wiley &amp;amp; Sons"/&gt;    </code></p><p><code>116</code><code>&lt;meta name="citation_reference" content="citation_title=Cox&amp;amp;apos;s regression model for counting processes, a large sample study.;citation_author=PG Andersen;citation_author=RD Gill;citation_journal_title=Annals of Statistics;citation_volume=10;citation_number=10;citation_first_page=1100;citation_last_page=1120;citation_publication_date=1982;"/&gt;    </code></p><p><code>117</code><code>&lt;meta name="citation_reference" content="citation_title=R: A language and environment for statistical computing;citation_publication_date=2009;citation_publisher=R Foundation for Statistical Computing"/&gt;    </code></p><p><code>118</code><code>          </code></p><p><code>119</code><code>          </code></p><p><code>120</code><code>&lt;!-- DoubleClick overall ad setup script --&gt;</code></p><p><code>121</code><code>&lt;script type='text/javascript'&gt;</code></p><p><code>122</code><code>  var googletag = googletag || {};</code></p><p><code>123</code><code>  googletag.cmd = googletag.cmd || [];</code></p><p><code>124</code><code>  (function() {</code></p><p><code>125</code><code>    var gads = document.createElement('script');</code></p><p><code>126</code><code>    gads.async = true;</code></p><p><code>127</code><code>    gads.type = 'text/javascript';</code></p><p><code>128</code><code>    var useSSL = 'https:' == document.location.protocol;</code></p><p><code>129</code><code>    gads.src = (useSSL ? 'https:' : 'http:') +</code></p><p><code>130</code><code>        '//www.googletagservices.com/tag/js/gpt.js';</code></p><p><code>131</code><code>    var node = document.getElementsByTagName('script')[0];</code></p><p><code>132</code><code>    node.parentNode.insertBefore(gads, node);</code></p><p><code>133</code><code>  })();</code></p><p><code>134</code><code>&lt;/script&gt;</code></p><p><code>135</code><code>          </code></p><p><code>136</code><code>&lt;!-- DoubleClick ad slot setup script --&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>  &lt;script id="doubleClickSetupScript" type='text/javascript'&gt;</code></p><p><code>139</code><code>    googletag.cmd.push(function() {</code></p><p><code>140</code><code>  googletag.defineSlot('/75507958/PONE_728x90_ATF', [728, 90], 'div-gpt-ad-1458247671871-0').addService(googletag.pubads());</code></p><p><code>141</code><code>  googletag.defineSlot('/75507958/PONE_160x600_BTF', [160, 600], 'div-gpt-ad-1458247671871-1').addService(googletag.pubads());</code></p><p><code>142</code><code>      var personalizedAds = window.plosCookieConsent &amp;&amp; window.plosCookieConsent.hasConsented('advertising');</code></p><p><code>143</code><code>      googletag.pubads().setRequestNonPersonalizedAds(personalizedAds ? 0 : 1);</code></p><p><code>144</code><code>      googletag.pubads().enableSingleRequest();</code></p><p><code>145</code><code>      googletag.enableServices();</code></p><p><code>146</code><code>    });</code></p><p><code>147</code><code>  &lt;/script&gt;</code></p><p><code>148</code><code>          </code></p><p><code>149</code><code>          </code></p><p><code>150</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>151</code><code>    var WombatConfig = WombatConfig || {};</code></p><p><code>152</code><code>    WombatConfig.journalKey = "PLoSONE";</code></p><p><code>153</code><code>    WombatConfig.journalName = "PLOS ONE";</code></p><p><code>154</code><code>    WombatConfig.figurePath = "/plosone/article/figure/image";</code></p><p><code>155</code><code>    WombatConfig.figShareInstitutionString = "plos";</code></p><p><code>156</code><code>    WombatConfig.doiResolverPrefix = "https://dx.plos.org/";</code></p><p><code>157</code><code>&lt;/script&gt;</code></p><p><code>158</code><code>          </code></p><p><code>159</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>160</code><code>  var WombatConfig = WombatConfig || {};</code></p><p><code>161</code><code>  WombatConfig.metrics = WombatConfig.metrics || {};</code></p><p><code>162</code><code>  WombatConfig.metrics.referenceUrl      = "http://lagotto.io/plos";</code></p><p><code>163</code><code>  WombatConfig.metrics.googleScholarUrl  = "https://scholar.google.com/scholar";</code></p><p><code>164</code><code>  WombatConfig.metrics.googleScholarCitationUrl  = WombatConfig.metrics.googleScholarUrl + "?hl=en&amp;lr=&amp;q=";</code></p><p><code>165</code><code>  WombatConfig.metrics.crossrefUrl  = "https://www.crossref.org";</code></p><p><code>166</code><code>&lt;/script&gt;</code></p><p><code>167</code><code>&lt;script defer="defer" src="/resource/js/defer.js?1ddb586ea4db199fcafa"&gt;&lt;/script&gt;&lt;script src="/resource/js/sync.js?1ddb586ea4db199fcafa"&gt;&lt;/script&gt;</code></p><p><code>168</code><code>&lt;script src="/resource/js/vendor/jquery.min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>169</code><code>          </code></p><p><code>170</code><code>          &lt;script type="text/javascript" src="https://widgets.figshare.com/static/figshare.js"&gt;&lt;/script&gt;</code></p><p><code>171</code><code>          </code></p><p><code>172</code><code>&lt;script src="/resource/js/vendor/fastclick/lib/fastclick.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>173</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>174</code><code>&lt;script src="/resource/js/vendor/underscore-min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>175</code><code>&lt;script src="/resource/js/vendor/underscore.string.min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>176</code><code>&lt;script src="/resource/js/vendor/moment.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>177</code><code>          </code></p><p><code>178</code><code>          </code></p><p><code>179</code><code>&lt;script src="/resource/js/vendor/jquery-ui-effects.min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>180</code><code>          </code></p><p><code>181</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.tooltip.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>182</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>183</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.tab.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>184</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.reveal.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>185</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.slider.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>186</code><code>          </code></p><p><code>187</code><code>&lt;script src="/resource/js/util/utils.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>188</code><code>&lt;script src="/resource/js/components/toggle.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>189</code><code>&lt;script src="/resource/js/components/truncate_elem.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>190</code><code>&lt;script src="/resource/js/components/tooltip_hover.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>191</code><code>&lt;script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>192</code><code>          </code></p><p><code>193</code><code>&lt;!--For Google Tag manager to be able to track site information  --&gt;</code></p><p><code>194</code><code>&lt;script&gt;</code></p><p><code>195</code><code>          </code></p><p><code>196</code><code>  dataLayer = [{</code></p><p><code>197</code><code>    'mobileSite': 'false',</code></p><p><code>198</code><code>    'desktopSite': 'true'</code></p><p><code>199</code><code>  }];</code></p><p><code>200</code><code>          </code></p><p><code>201</code><code>&lt;/script&gt;</code></p><p><code>202</code><code>          </code></p><p><code>203</code><code>    &lt;title&gt;Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer | PLOS ONE&lt;/title&gt;</code></p><p><code>204</code><code>&lt;/head&gt;</code></p><p><code>205</code><code>          </code></p><p><code>206</code><code>&lt;body class="article plosone"&gt;</code></p><p><code>207</code><code>          </code></p><p><code>208</code><code>          </code></p><p><code>209</code><code>&lt;!-- Google Tag Manager --&gt;</code></p><p><code>210</code><code>&lt;noscript&gt;&lt;iframe src="//www.googletagmanager.com/ns.html?id=GTM-TP26BH"</code></p><p><code>211</code><code>                  height="0" width="0" style="display:none;visibility:hidden"&gt;&lt;/iframe&gt;&lt;/noscript&gt;</code></p><p><code>212</code><code>&lt;script&gt;</code></p><p><code>213</code><code>  (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':</code></p><p><code>214</code><code>    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],</code></p><p><code>215</code><code>    j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=</code></p><p><code>216</code><code>    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);</code></p><p><code>217</code><code>})(window,document,'script','dataLayer','GTM-TP26BH');</code></p><p><code>218</code><code>&lt;/script&gt;</code></p><p><code>219</code><code>          </code></p><p><code>220</code><code>&lt;noscript&gt;&lt;iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQQMGF"</code></p><p><code>221</code><code>                  height="0" width="0" style="display:none;visibility:hidden"&gt;&lt;/iframe&gt;&lt;/noscript&gt;</code></p><p><code>222</code><code>&lt;script&gt;(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':</code></p><p><code>223</code><code>    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],</code></p><p><code>224</code><code>    j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=</code></p><p><code>225</code><code>    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);</code></p><p><code>226</code><code>})(window,document,'script','dataLayer','GTM-MQQMGF');&lt;/script&gt;</code></p><p><code>227</code><code>&lt;!-- End Google Tag Manager --&gt;</code></p><p><code>228</code><code>          </code></p><p><code>229</code><code>&lt;!-- New Relic --&gt;</code></p><p><code>230</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>231</code><code>  ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}};</code></p><p><code>232</code><code>  window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o&lt;n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&amp;&amp;console.log(t)}catch(e){}}var o,i=t("ee"),a=t(32),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&amp;&amp;"function"==typeof console.log&amp;&amp;(s.console=!0,o.indexOf("dev")!==-1&amp;&amp;(s.dev=!0),o.indexOf("nr_dev")!==-1&amp;&amp;(s.nrDev=!0))}catch(c){}s.nrDev&amp;&amp;i.on("internal-error",function(t){r(t.stack)}),s.dev&amp;&amp;i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&amp;&amp;(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&amp;&amp;u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(33),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&amp;&amp;(t(14),t(13),"addEventListener"in window&amp;&amp;t(7),c.xhrWrappable&amp;&amp;t(15),d=!0)}s.on("fn-start",function(t,e,n){d&amp;&amp;(l+=1)}),s.on("fn-err",function(t,e,n){d&amp;&amp;!n[p]&amp;&amp;(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&amp;&amp;!this.thrown&amp;&amp;l&gt;0&amp;&amp;(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&amp;&amp;i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&amp;&amp;y.xhrWrappable&amp;&amp;!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),P=t(15),S=t(10),M=t("ee"),N=M.get("tracer"),C=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),S.on(p,r),M.on(d,o),b.on(l,o),S.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),P.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),N.buffer([u,"no-"+u]),S.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(S,"new-jsonp"),a(S,"jsonp-end"),a(S,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,C(!0)),w[v]("load",i,C(!0)),w[v]("popstate",function(){i(0,U&gt;1)},C(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&amp;&amp;window.performance.timing&amp;&amp;window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&amp;&amp;t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&amp;&amp;(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&amp;&amp;s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&amp;&amp;(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&amp;&amp;"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&amp;&amp;!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&amp;&amp;o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&amp;&amp;(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&amp;&amp;("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&amp;&amp;(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&amp;&amp;e[m].dt&amp;&amp;(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(33),a=t(32);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&amp;&amp;p&amp;&amp;l&amp;&amp;(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&amp;&amp;(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&amp;&amp;window.history.constructor&amp;&amp;window.history.constructor.prototype,a=window.history;i&amp;&amp;i.pushState&amp;&amp;i.replaceState&amp;&amp;(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&amp;&amp;"string"==typeof t.nodeName&amp;&amp;"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&amp;&amp;e.length&gt;=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&amp;](?:callback|cb)=([^&amp;#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&amp;&amp;Node.prototype&amp;&amp;Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&amp;&amp;(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(32),f=NREUM.o.PR;e.exports=i,f&amp;&amp;(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&amp;&amp;i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&amp;&amp;!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&amp;&amp;e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState&gt;3&amp;&amp;!e.resolved&amp;&amp;(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&amp;&amp;(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t&lt;x.length;t++)r([],x[t]);x.length&amp;&amp;(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&amp;&amp;v.resolve();if(!w&amp;&amp;!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&amp;&amp;t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&amp;&amp;p())&amp;&amp;(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&amp;&amp;!u()||!t.sameOrigin&amp;&amp;c(t)&amp;&amp;d())&amp;&amp;(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&amp;&amp;"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&amp;&amp;r!==i&amp;&amp;(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&amp;&amp;c(t)}function c(t){var e=!1,n={};if("init"in NREUM&amp;&amp;"distributed_tracing"in NREUM.init&amp;&amp;(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r&lt;n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&amp;&amp;t.protocol===o.protocol&amp;&amp;t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&amp;&amp;"distributed_tracing"in NREUM.init&amp;&amp;!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&amp;&amp;"distributed_tracing"in NREUM.init&amp;&amp;!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&amp;&amp;"distributed_tracing"in NREUM.init&amp;&amp;NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&amp;&amp;"distributed_tracing"in NREUM.init&amp;&amp;!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(29),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r&lt;p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&amp;&amp;(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&amp;&amp;(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&amp;&amp;(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&amp;&amp;!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=NREUM.o.REQ,y=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&amp;&amp;(h&gt;34||h&lt;10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&amp;&amp;"xpid"in NREUM.loader_config&amp;&amp;this.sameOrigin&amp;&amp;e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&amp;&amp;(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&amp;&amp;(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&amp;&amp;e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&amp;&amp;(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&amp;&amp;r){var i=m(r);i&amp;&amp;(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&amp;&amp;(o.onloadCalled||"function"!=typeof e.onload))&amp;&amp;o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s&lt;p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&amp;&amp;"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&amp;&amp;!this.xhrGuids[n]&amp;&amp;(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&amp;&amp;this.xhrGuids[n]&amp;&amp;(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof y&amp;&amp;"load"===t[0]&amp;&amp;u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof y&amp;&amp;"load"===t[0]&amp;&amp;u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof y&amp;&amp;("onload"===n&amp;&amp;(this.onload=!0),("load"===(t[0]&amp;&amp;t[0].type)||this.onload)&amp;&amp;(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&amp;&amp;u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&amp;&amp;(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&amp;&amp;(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&amp;&amp;t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&amp;&amp;t[0].url?n=t[0].url:window.URL&amp;&amp;t[0]&amp;&amp;t[0]instanceof URL&amp;&amp;(n=t[0].href),n&amp;&amp;(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&amp;&amp;(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&amp;&amp;t[0]&amp;&amp;t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&amp;&amp;(this.dt=o),t.length&gt;1?t[1]=i:t.push(i)}else t[0]&amp;&amp;t[0].headers&amp;&amp;e(t[0].headers,o)&amp;&amp;(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length&gt;=1&amp;&amp;(this.target=t[0]),t.length&gt;=2&amp;&amp;(this.opts=t[1]);var n,r=this.opts||{},i=this.target;"string"==typeof i?n=i:"object"==typeof i&amp;&amp;i instanceof g?n=i.url:window.URL&amp;&amp;"object"==typeof i&amp;&amp;i instanceof URL&amp;&amp;(n=i.href),o(this,n);var s=(""+(i&amp;&amp;i instanceof g&amp;&amp;i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}),u.on("fetch-done",function(t,e){this.endTime=a.now(),this.params||(this.params={}),this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&amp;&amp;this.rxSize.length&gt;0&amp;&amp;(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&amp;&amp;i[1]&amp;&amp;(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&amp;&amp;"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&amp;&amp;(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&amp;&amp;e.port===n.port;return o.sameOrigin=a&amp;&amp;(!e.hostname||s),"/"===o.pathname&amp;&amp;(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&amp;&amp;null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(32),s=t(33),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&amp;&amp;(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&amp;&amp;(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r&lt;n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&amp;&amp;t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&amp;&amp;t instanceof ArrayBuffer&amp;&amp;t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&amp;&amp;t instanceof Blob&amp;&amp;t.size)return t.size;if(!("undefined"!=typeof FormData&amp;&amp;t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&amp;&amp;(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&amp;&amp;performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(34);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t){return!(!t||!t.protocol||"file:"===t.protocol)}e.exports=r},{}],28:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?p("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&amp;&amp;p("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length&gt;0){var r=n[n.length-1];if(c&amp;&amp;c&lt;r.startTime)return;p("lcp",[r])}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||p("cls",[t])})}function a(t){if(t instanceof v&amp;&amp;!g){var e=Math.round(t.timeStamp),n={type:t.type};e&lt;=l.now()?n.fid=l.now()-e:e&gt;l.offset&amp;&amp;e&lt;=Date.now()?(e-=l.offset,n.fid=l.now()-e):e=l.now(),g=!0,p("timing",["fi",e,n])}}function s(t){"hidden"===t&amp;&amp;(c=l.now(),p("pageHide",[c]))}if(!("init"in NREUM&amp;&amp;"page_view_timing"in NREUM.init&amp;&amp;"enabled"in NREUM.init.page_view_timing&amp;&amp;NREUM.init.page_view_timing.enabled===!1)){var c,f,u,d,p=t("handle"),l=t("loader"),h=t(31),m=t(23),v=NREUM.o.EV;if("PerformanceObserver"in window&amp;&amp;"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(w){}u=new PerformanceObserver(o);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(w){}d=new PerformanceObserver(i);try{d.observe({type:"layout-shift",buffered:!0})}catch(w){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(t){document.addEventListener(t,a,m(!1))})}h(s)}},{}],29:[function(t,e,n){function r(){function t(){return e?15&amp;e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&amp;&amp;r.getRandomValues&amp;&amp;(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s&lt;i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&amp;t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&amp;n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&amp;&amp;o.getRandomValues&amp;&amp;Uint8Array&amp;&amp;(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a&lt;t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],30:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a&lt;r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&amp;&amp;s.indexOf("Chrome")===-1&amp;&amp;s.indexOf("Chromium")===-1&amp;&amp;(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],31:[function(t,e,n){function r(t){function e(){t(s&amp;&amp;document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&amp;&amp;a&amp;&amp;document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&amp;&amp;(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],32:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&amp;&amp;(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],33:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&amp;&amp;(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o&lt;0?0:o);++r&lt;o;)i[r]=t[e+r];return i}e.exports=r},{}],34:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&amp;&amp;window.performance.timing&amp;&amp;"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&amp;&amp;t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&amp;&amp;(a=!0),!l.aborted||i){t&amp;&amp;a&amp;&amp;t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u&lt;f;u++)c[u].apply(s,r);var p=d[y[n]];return p&amp;&amp;p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r&lt;n.length;r++)n[r]===e&amp;&amp;n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&amp;&amp;(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(32),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&amp;&amp;Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&amp;&amp;"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!P++){var t=T.info=NREUM.info,e=v.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&amp;&amp;t.licenseKey&amp;&amp;t.applicationID&amp;&amp;e))return f.abort();c(R,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+T.offset],null,"api"),s("timing",["load",n]);var r=v.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=h+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===v.readyState&amp;&amp;i()}function i(){s("mark",["domContent",a()+T.offset],null,"api")}var a=t(26),s=t("handle"),c=t(32),f=t("ee"),u=t(30),d=t(27),p=t(21),l=t(23),h=p.getConfiguration("ssl")===!1?"http":"https",m=window,v=m.document,w="addEventListener",g="attachEvent",y=m.XMLHttpRequest,x=y&amp;&amp;y.prototype,b=!d(m.location);NREUM.o={ST:setTimeout,SI:m.setImmediate,CT:clearTimeout,XHR:y,REQ:m.Request,EV:m.Event,PR:m.Promise,MO:m.MutationObserver};var E=""+location,R={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1212.min.js"},O=y&amp;&amp;x&amp;&amp;x[w]&amp;&amp;!/CriOS/.test(navigator.userAgent),T=e.exports={offset:a.getLastTimestamp(),now:a,origin:E,features:{},xhrWrappable:O,userAgent:u,disabled:b};if(!b){t(20),t(28),v[w]?(v[w]("DOMContentLoaded",i,l(!1)),m[w]("load",r,l(!1))):(v[g]("onreadystatechange",o),m[g]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var P=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f&lt;e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&amp;&amp;Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&amp;&amp;(e[a]=t[a]);return e}function a(t){return!(t&amp;&amp;t instanceof Function&amp;&amp;t.apply&amp;&amp;!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n&lt;t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(33),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</code></p><p><code>233</code><code>  ;NREUM.loader_config={accountID:"804283",trustKey:"804283",agentID:"402703674",licenseKey:"cf99e8d2a3",applicationID:"402703674"}</code></p><p><code>234</code><code>  ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"cf99e8d2a3",</code></p><p><code>235</code><code>    // Modified this value from the generated script, to pass prod vs dev</code></p><p><code>236</code><code>    applicationID: window.location.hostname.includes('journals.plos.org') ? "402703674" : "402694889",</code></p><p><code>237</code><code>    sa:1}</code></p><p><code>238</code><code>&lt;/script&gt;</code></p><p><code>239</code><code>&lt;!-- End New Relic --&gt;</code></p><p><code>240</code><code>          </code></p><p><code>241</code><code>&lt;script defer data-domain="journals.plos.org,journals.dev.chs.plos.cloud" src="https://plausible.io/js/script.manual.outbound-links.js"&gt;&lt;/script&gt;</code></p><p><code>242</code><code>&lt;!-- define the `plausible` function to manually trigger events --&gt;</code></p><p><code>243</code><code>&lt;script&gt;window.plausible = window.plausible || function() { (window.plausible.q = window.plausible.q || []).push(arguments) }&lt;/script&gt;</code></p><p><code>244</code><code>&lt;!-- trigger pageview --&gt;</code></p><p><code>245</code><code>&lt;script&gt;</code></p><p><code>246</code><code>  function prepareUrl(params) {</code></p><p><code>247</code><code>    const url = new URL(location.href)</code></p><p><code>248</code><code>    const queryParams = new URLSearchParams(location.search)</code></p><p><code>249</code><code>    let customUrl = url.protocol + "//" + url.hostname + url.pathname</code></p><p><code>250</code><code>    for (const paramName of params) {</code></p><p><code>251</code><code>      const paramValue = queryParams.get(paramName)</code></p><p><code>252</code><code>      if (paramValue) customUrl = customUrl + '/' + paramValue</code></p><p><code>253</code><code>    }</code></p><p><code>254</code><code>    return customUrl + location.search</code></p><p><code>255</code><code>  }</code></p><p><code>256</code><code>  plausible('pageview', { u: prepareUrl(["id"]) })</code></p><p><code>257</code><code>&lt;/script&gt;</code></p><p><code>258</code><code>          </code></p><p><code>259</code><code>          </code></p><p><code>260</code><code>          </code></p><p><code>261</code><code>&lt;header&gt;</code></p><p><code>262</code><code>  &lt;div id="topslot" class="head-top"&gt;</code></p><p><code>263</code><code>  &lt;a id="skip-to-content" tabindex="0" class="button" href="#main-content"&gt;</code></p><p><code>264</code><code>    Skip to main content</code></p><p><code>265</code><code>  &lt;/a&gt;</code></p><p><code>266</code><code>          </code></p><p><code>267</code><code>&lt;div class="center"&gt;</code></p><p><code>268</code><code>&lt;div class="title"&gt;Advertisement&lt;/div&gt;</code></p><p><code>269</code><code>&lt;!-- DoubleClick Ad Zone --&gt;</code></p><p><code>270</code><code>  &lt;div class='advertisement' id='div-gpt-ad-1458247671871-0' style='width:728px; height:90px;'&gt;</code></p><p><code>271</code><code>    &lt;script type='text/javascript'&gt;</code></p><p><code>272</code><code>      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-0'); });</code></p><p><code>273</code><code>    &lt;/script&gt;</code></p><p><code>274</code><code>  &lt;/div&gt;</code></p><p><code>275</code><code>&lt;/div&gt;</code></p><p><code>276</code><code>  &lt;/div&gt;</code></p><p><code>277</code><code>          </code></p><p><code>278</code><code>  &lt;div id="user" class="nav" data-user-management-url="https://community.plos.org"&gt;</code></p><p><code>279</code><code>  &lt;/div&gt;</code></p><p><code>280</code><code>  &lt;div id="pagehdr"&gt;</code></p><p><code>281</code><code>          </code></p><p><code>282</code><code>    &lt;nav class="nav-main"&gt;</code></p><p><code>283</code><code>          </code></p><p><code>284</code><code>          </code></p><p><code>285</code><code>          </code></p><p><code>286</code><code>          </code></p><p><code>287</code><code>&lt;h1 class="logo"&gt;</code></p><p><code>288</code><code>  &lt;a href="/plosone/."&gt;PLOS ONE&lt;/a&gt;</code></p><p><code>289</code><code>&lt;/h1&gt;</code></p><p><code>290</code><code>          </code></p><p><code>291</code><code>&lt;section class="top-bar-section"&gt; </code></p><p><code>292</code><code>          </code></p><p><code>293</code><code>&lt;ul class="nav-elements"&gt;</code></p><p><code>294</code><code>          </code></p><p><code>295</code><code>          </code></p><p><code>296</code><code>    &lt;li class="multi-col-parent menu-section-header has-dropdown" id="publish"&gt;</code></p><p><code>297</code><code>    Publish</code></p><p><code>298</code><code>      &lt;div class="dropdown mega "&gt;</code></p><p><code>299</code><code>        &lt;ul class="multi-col" id="publish-dropdown-list"&gt;</code></p><p><code>300</code><code>          </code></p><p><code>301</code><code>  &lt;li class="menu-section-header " id="submissions"&gt;</code></p><p><code>302</code><code>    &lt;span class="menu-section-header-title"&gt;  Submissions &lt;/span&gt;</code></p><p><code>303</code><code>          </code></p><p><code>304</code><code>    &lt;ul class="menu-section "</code></p><p><code>305</code><code>        id="submissions-dropdown-list"&gt;</code></p><p><code>306</code><code>      &lt;li&gt;</code></p><p><code>307</code><code>    &lt;a href="/plosone/s/getting-started" &gt;Getting Started&lt;/a&gt;</code></p><p><code>308</code><code>  &lt;/li&gt;</code></p><p><code>309</code><code>          </code></p><p><code>310</code><code>      &lt;li&gt;</code></p><p><code>311</code><code>    &lt;a href="/plosone/s/submission-guidelines" &gt;Submission Guidelines&lt;/a&gt;</code></p><p><code>312</code><code>  &lt;/li&gt;</code></p><p><code>313</code><code>          </code></p><p><code>314</code><code>      &lt;li&gt;</code></p><p><code>315</code><code>    &lt;a href="/plosone/s/figures" &gt;Figures&lt;/a&gt;</code></p><p><code>316</code><code>  &lt;/li&gt;</code></p><p><code>317</code><code>          </code></p><p><code>318</code><code>      &lt;li&gt;</code></p><p><code>319</code><code>    &lt;a href="/plosone/s/tables" &gt;Tables&lt;/a&gt;</code></p><p><code>320</code><code>  &lt;/li&gt;</code></p><p><code>321</code><code>          </code></p><p><code>322</code><code>      &lt;li&gt;</code></p><p><code>323</code><code>    &lt;a href="/plosone/s/supporting-information" &gt;Supporting Information&lt;/a&gt;</code></p><p><code>324</code><code>  &lt;/li&gt;</code></p><p><code>325</code><code>          </code></p><p><code>326</code><code>      &lt;li&gt;</code></p><p><code>327</code><code>    &lt;a href="/plosone/s/latex" &gt;LaTeX&lt;/a&gt;</code></p><p><code>328</code><code>  &lt;/li&gt;</code></p><p><code>329</code><code>          </code></p><p><code>330</code><code>      &lt;li&gt;</code></p><p><code>331</code><code>    &lt;a href="/plosone/s/what-we-publish" &gt;What We Publish&lt;/a&gt;</code></p><p><code>332</code><code>  &lt;/li&gt;</code></p><p><code>333</code><code>          </code></p><p><code>334</code><code>      &lt;li&gt;</code></p><p><code>335</code><code>    &lt;a href="/plosone/s/preprints" &gt;Preprints&lt;/a&gt;</code></p><p><code>336</code><code>  &lt;/li&gt;</code></p><p><code>337</code><code>          </code></p><p><code>338</code><code>      &lt;li&gt;</code></p><p><code>339</code><code>    &lt;a href="/plosone/s/revising-your-manuscript" &gt;Revising Your Manuscript&lt;/a&gt;</code></p><p><code>340</code><code>  &lt;/li&gt;</code></p><p><code>341</code><code>          </code></p><p><code>342</code><code>      &lt;li&gt;</code></p><p><code>343</code><code>    &lt;a href="/plosone/s/submit-now" &gt;Submit Now&lt;/a&gt;</code></p><p><code>344</code><code>  &lt;/li&gt;</code></p><p><code>345</code><code>          </code></p><p><code>346</code><code>      &lt;li&gt;</code></p><p><code>347</code><code>    &lt;a href="https://collections.plos.org/s/calls-for-papers" &gt;Calls for Papers&lt;/a&gt;</code></p><p><code>348</code><code>  &lt;/li&gt;</code></p><p><code>349</code><code>          </code></p><p><code>350</code><code>    &lt;/ul&gt;</code></p><p><code>351</code><code>          </code></p><p><code>352</code><code>  &lt;/li&gt;</code></p><p><code>353</code><code>          </code></p><p><code>354</code><code>          </code></p><p><code>355</code><code>  &lt;li class="menu-section-header " id="policies"&gt;</code></p><p><code>356</code><code>    &lt;span class="menu-section-header-title"&gt;  Policies &lt;/span&gt;</code></p><p><code>357</code><code>          </code></p><p><code>358</code><code>    &lt;ul class="menu-section "</code></p><p><code>359</code><code>        id="policies-dropdown-list"&gt;</code></p><p><code>360</code><code>      &lt;li&gt;</code></p><p><code>361</code><code>    &lt;a href="/plosone/s/best-practices-in-research-reporting" &gt;Best Practices in Research Reporting&lt;/a&gt;</code></p><p><code>362</code><code>  &lt;/li&gt;</code></p><p><code>363</code><code>          </code></p><p><code>364</code><code>      &lt;li&gt;</code></p><p><code>365</code><code>    &lt;a href="/plosone/s/human-subjects-research" &gt;Human Subjects Research&lt;/a&gt;</code></p><p><code>366</code><code>  &lt;/li&gt;</code></p><p><code>367</code><code>          </code></p><p><code>368</code><code>      &lt;li&gt;</code></p><p><code>369</code><code>    &lt;a href="/plosone/s/animal-research" &gt;Animal Research&lt;/a&gt;</code></p><p><code>370</code><code>  &lt;/li&gt;</code></p><p><code>371</code><code>          </code></p><p><code>372</code><code>      &lt;li&gt;</code></p><p><code>373</code><code>    &lt;a href="/plosone/s/competing-interests" &gt;Competing Interests&lt;/a&gt;</code></p><p><code>374</code><code>  &lt;/li&gt;</code></p><p><code>375</code><code>          </code></p><p><code>376</code><code>      &lt;li&gt;</code></p><p><code>377</code><code>    &lt;a href="/plosone/s/disclosure-of-funding-sources" &gt;Disclosure of Funding Sources&lt;/a&gt;</code></p><p><code>378</code><code>  &lt;/li&gt;</code></p><p><code>379</code><code>          </code></p><p><code>380</code><code>      &lt;li&gt;</code></p><p><code>381</code><code>    &lt;a href="/plosone/s/licenses-and-copyright" &gt;Licenses and Copyright&lt;/a&gt;</code></p><p><code>382</code><code>  &lt;/li&gt;</code></p><p><code>383</code><code>          </code></p><p><code>384</code><code>      &lt;li&gt;</code></p><p><code>385</code><code>    &lt;a href="/plosone/s/data-availability" &gt;Data Availability&lt;/a&gt;</code></p><p><code>386</code><code>  &lt;/li&gt;</code></p><p><code>387</code><code>          </code></p><p><code>388</code><code>      &lt;li&gt;</code></p><p><code>389</code><code>    &lt;a href="/plosone/s/complementary-research" &gt;Complementary Research&lt;/a&gt;</code></p><p><code>390</code><code>  &lt;/li&gt;</code></p><p><code>391</code><code>          </code></p><p><code>392</code><code>      &lt;li&gt;</code></p><p><code>393</code><code>    &lt;a href="/plosone/s/materials-software-and-code-sharing" &gt;Materials, Software and Code Sharing&lt;/a&gt;</code></p><p><code>394</code><code>  &lt;/li&gt;</code></p><p><code>395</code><code>          </code></p><p><code>396</code><code>      &lt;li&gt;</code></p><p><code>397</code><code>    &lt;a href="/plosone/s/ethical-publishing-practice" &gt;Ethical Publishing Practice&lt;/a&gt;</code></p><p><code>398</code><code>  &lt;/li&gt;</code></p><p><code>399</code><code>          </code></p><p><code>400</code><code>      &lt;li&gt;</code></p><p><code>401</code><code>    &lt;a href="/plosone/s/authorship" &gt;Authorship&lt;/a&gt;</code></p><p><code>402</code><code>  &lt;/li&gt;</code></p><p><code>403</code><code>          </code></p><p><code>404</code><code>      &lt;li&gt;</code></p><p><code>405</code><code>    &lt;a href="/plosone/s/corrections-expressions-of-concern-and-retractions" &gt;Corrections, Expressions of Concern, and Retractions&lt;/a&gt;</code></p><p><code>406</code><code>  &lt;/li&gt;</code></p><p><code>407</code><code>          </code></p><p><code>408</code><code>    &lt;/ul&gt;</code></p><p><code>409</code><code>          </code></p><p><code>410</code><code>  &lt;/li&gt;</code></p><p><code>411</code><code>          </code></p><p><code>412</code><code>          </code></p><p><code>413</code><code>  &lt;li class="menu-section-header " id="manuscript-review-and-publication"&gt;</code></p><p><code>414</code><code>    &lt;span class="menu-section-header-title"&gt;  Manuscript Review and Publication &lt;/span&gt;</code></p><p><code>415</code><code>          </code></p><p><code>416</code><code>    &lt;ul class="menu-section "</code></p><p><code>417</code><code>        id="manuscript-review-and-publication-dropdown-list"&gt;</code></p><p><code>418</code><code>      &lt;li&gt;</code></p><p><code>419</code><code>    &lt;a href="/plosone/s/criteria-for-publication" &gt;Criteria for Publication&lt;/a&gt;</code></p><p><code>420</code><code>  &lt;/li&gt;</code></p><p><code>421</code><code>          </code></p><p><code>422</code><code>      &lt;li&gt;</code></p><p><code>423</code><code>    &lt;a href="/plosone/s/editorial-and-peer-review-process" &gt;Editorial and Peer Review Process&lt;/a&gt;</code></p><p><code>424</code><code>  &lt;/li&gt;</code></p><p><code>425</code><code>          </code></p><p><code>426</code><code>      &lt;li&gt;</code></p><p><code>427</code><code>    &lt;a href="https://plos.org/resources/editor-center" &gt;Editor Center&lt;/a&gt;</code></p><p><code>428</code><code>  &lt;/li&gt;</code></p><p><code>429</code><code>          </code></p><p><code>430</code><code>      &lt;li&gt;</code></p><p><code>431</code><code>    &lt;a href="/plosone/s/resources-for-editors" &gt;Resources for Editors&lt;/a&gt;</code></p><p><code>432</code><code>  &lt;/li&gt;</code></p><p><code>433</code><code>          </code></p><p><code>434</code><code>      &lt;li&gt;</code></p><p><code>435</code><code>    &lt;a href="/plosone/s/reviewer-guidelines" &gt;Guidelines for Reviewers&lt;/a&gt;</code></p><p><code>436</code><code>  &lt;/li&gt;</code></p><p><code>437</code><code>          </code></p><p><code>438</code><code>      &lt;li&gt;</code></p><p><code>439</code><code>    &lt;a href="/plosone/s/accepted-manuscripts" &gt;Accepted Manuscripts&lt;/a&gt;</code></p><p><code>440</code><code>  &lt;/li&gt;</code></p><p><code>441</code><code>          </code></p><p><code>442</code><code>      &lt;li&gt;</code></p><p><code>443</code><code>    &lt;a href="/plosone/s/comments" &gt;Comments&lt;/a&gt;</code></p><p><code>444</code><code>  &lt;/li&gt;</code></p><p><code>445</code><code>          </code></p><p><code>446</code><code>    &lt;/ul&gt;</code></p><p><code>447</code><code>          </code></p><p><code>448</code><code>  &lt;/li&gt;</code></p><p><code>449</code><code>        &lt;/ul&gt;</code></p><p><code>450</code><code>          &lt;div class="calloutcontainer"&gt;</code></p><p><code>451</code><code>          </code></p><p><code>452</code><code>          </code></p><p><code>453</code><code>          </code></p><p><code>454</code><code>  &lt;h3 class="callout-headline"&gt;Submit Your Manuscript&lt;/h3&gt;</code></p><p><code>455</code><code>          </code></p><p><code>456</code><code>  &lt;div class="action-contain"&gt;</code></p><p><code>457</code><code>  &lt;p class="callout-content"&gt;</code></p><p><code>458</code><code>  Discover a faster, simpler path to publishing in a high-quality journal. &lt;em&gt;PLOS ONE&lt;/em&gt; promises fair, rigorous peer review,</code></p><p><code>459</code><code>  broad scope, and wide readership – a perfect fit for your research every time.</code></p><p><code>460</code><code>  &lt;/p&gt;</code></p><p><code>461</code><code>          </code></p><p><code>462</code><code>  &lt;p class="button-contain special"&gt;</code></p><p><code>463</code><code>    &lt;a class="button button-default" href="/plosone/static/publish"&gt;</code></p><p><code>464</code><code>     Learn More</code></p><p><code>465</code><code>    &lt;/a&gt;</code></p><p><code>466</code><code>    &lt;a class="button-link" href="https://www.editorialmanager.com/pone/default.asp"&gt;</code></p><p><code>467</code><code>      Submit Now</code></p><p><code>468</code><code>    &lt;/a&gt;</code></p><p><code>469</code><code>  &lt;/p&gt;</code></p><p><code>470</code><code>  &lt;/div&gt;  &lt;!-- opens in siteMenuCalloutDescription --&gt;</code></p><p><code>471</code><code>          </code></p><p><code>472</code><code>          </code></p><p><code>473</code><code>          &lt;/div&gt;</code></p><p><code>474</code><code>      &lt;/div&gt;</code></p><p><code>475</code><code>    &lt;/li&gt;</code></p><p><code>476</code><code>          </code></p><p><code>477</code><code>          </code></p><p><code>478</code><code>          </code></p><p><code>479</code><code>  &lt;li class="menu-section-header has-dropdown " id="about"&gt;</code></p><p><code>480</code><code>    &lt;span class="menu-section-header-title"&gt;  About &lt;/span&gt;</code></p><p><code>481</code><code>          </code></p><p><code>482</code><code>    &lt;ul class="menu-section dropdown "</code></p><p><code>483</code><code>        id="about-dropdown-list"&gt;</code></p><p><code>484</code><code>      &lt;li&gt;</code></p><p><code>485</code><code>    &lt;a href="/plosone/static/publish" &gt;Why Publish with PLOS ONE&lt;/a&gt;</code></p><p><code>486</code><code>  &lt;/li&gt;</code></p><p><code>487</code><code>          </code></p><p><code>488</code><code>      &lt;li&gt;</code></p><p><code>489</code><code>    &lt;a href="/plosone/s/journal-information" &gt;Journal Information&lt;/a&gt;</code></p><p><code>490</code><code>  &lt;/li&gt;</code></p><p><code>491</code><code>          </code></p><p><code>492</code><code>      &lt;li&gt;</code></p><p><code>493</code><code>    &lt;a href="/plosone/s/staff-editors" &gt;Staff Editors&lt;/a&gt;</code></p><p><code>494</code><code>  &lt;/li&gt;</code></p><p><code>495</code><code>          </code></p><p><code>496</code><code>      &lt;li&gt;</code></p><p><code>497</code><code>    &lt;a href="/plosone/static/editorial-board" &gt;Editorial Board&lt;/a&gt;</code></p><p><code>498</code><code>  &lt;/li&gt;</code></p><p><code>499</code><code>          </code></p><p><code>500</code><code>      &lt;li&gt;</code></p><p><code>501</code><code>    &lt;a href="/plosone/s/section-editors" &gt;Section Editors&lt;/a&gt;</code></p><p><code>502</code><code>  &lt;/li&gt;</code></p><p><code>503</code><code>          </code></p><p><code>504</code><code>      &lt;li&gt;</code></p><p><code>505</code><code>    &lt;a href="/plosone/s/advisory-groups" &gt;Advisory Groups&lt;/a&gt;</code></p><p><code>506</code><code>  &lt;/li&gt;</code></p><p><code>507</code><code>          </code></p><p><code>508</code><code>      &lt;li&gt;</code></p><p><code>509</code><code>    &lt;a href="/plosone/s/find-and-read-articles" &gt;Find and Read Articles&lt;/a&gt;</code></p><p><code>510</code><code>  &lt;/li&gt;</code></p><p><code>511</code><code>          </code></p><p><code>512</code><code>      &lt;li&gt;</code></p><p><code>513</code><code>    &lt;a href="/plosone/s/publishing-information" &gt;Publishing Information&lt;/a&gt;</code></p><p><code>514</code><code>  &lt;/li&gt;</code></p><p><code>515</code><code>          </code></p><p><code>516</code><code>      &lt;li&gt;</code></p><p><code>517</code><code>    &lt;a href="https://plos.org/publication-fees" &gt;Publication Fees&lt;/a&gt;</code></p><p><code>518</code><code>  &lt;/li&gt;</code></p><p><code>519</code><code>          </code></p><p><code>520</code><code>      &lt;li&gt;</code></p><p><code>521</code><code>    &lt;a href="https://plos.org/press-and-media" &gt;Press and Media&lt;/a&gt;</code></p><p><code>522</code><code>  &lt;/li&gt;</code></p><p><code>523</code><code>          </code></p><p><code>524</code><code>      &lt;li&gt;</code></p><p><code>525</code><code>    &lt;a href="/plosone/s/contact" &gt;Contact&lt;/a&gt;</code></p><p><code>526</code><code>  &lt;/li&gt;</code></p><p><code>527</code><code>          </code></p><p><code>528</code><code>    &lt;/ul&gt;</code></p><p><code>529</code><code>          </code></p><p><code>530</code><code>  &lt;/li&gt;</code></p><p><code>531</code><code>          </code></p><p><code>532</code><code>  &lt;li data-js-tooltip-hover="trigger" class="subject-area menu-section-header"&gt;</code></p><p><code>533</code><code>  Browse</code></p><p><code>534</code><code>  &lt;/li&gt;</code></p><p><code>535</code><code>          </code></p><p><code>536</code><code>&lt;script src="/resource/js/vendor/jquery.hoverIntent.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>537</code><code>&lt;script src="/resource/js/components/menu_drop.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>538</code><code>&lt;script src="/resource/js/components/hover_delay.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>539</code><code>      &lt;li id="navsearch" class="head-search"&gt;</code></p><p><code>540</code><code>          </code></p><p><code>541</code><code>          </code></p><p><code>542</code><code>    &lt;form name="searchForm" action="/plosone/search" method="get"&gt;</code></p><p><code>543</code><code>      &lt;fieldset&gt;</code></p><p><code>544</code><code>        &lt;legend&gt;Search&lt;/legend&gt;</code></p><p><code>545</code><code>        &lt;label for="search"&gt;Search&lt;/label&gt;</code></p><p><code>546</code><code>        &lt;div class="search-contain"&gt;</code></p><p><code>547</code><code>          &lt;input id="search" type="text" name="q" placeholder="SEARCH" required/&gt;</code></p><p><code>548</code><code>          &lt;button id="headerSearchButton" type="submit" aria-label="Submit search"&gt;</code></p><p><code>549</code><code>            &lt;i title="Submit search" class="search-icon"&gt;&lt;/i&gt;</code></p><p><code>550</code><code>          &lt;/button&gt;</code></p><p><code>551</code><code>        &lt;/div&gt;</code></p><p><code>552</code><code>      &lt;/fieldset&gt;</code></p><p><code>553</code><code>      &lt;input type="hidden" name="filterJournals" value="PLoSONE"/&gt;</code></p><p><code>554</code><code>    &lt;/form&gt;</code></p><p><code>555</code><code>          </code></p><p><code>556</code><code>    &lt;a id="advSearch"</code></p><p><code>557</code><code>       href="/plosone/search"&gt;</code></p><p><code>558</code><code>      advanced search</code></p><p><code>559</code><code>    &lt;/a&gt;</code></p><p><code>560</code><code>          </code></p><p><code>561</code><code>          </code></p><p><code>562</code><code>          </code></p><p><code>563</code><code>          </code></p><p><code>564</code><code>&lt;script src="/resource/js/components/placeholder_style.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>565</code><code>      &lt;/li&gt;</code></p><p><code>566</code><code>          </code></p><p><code>567</code><code>      &lt;/ul&gt;     </code></p><p><code>568</code><code>      &lt;/section&gt;  </code></p><p><code>569</code><code>    &lt;/nav&gt;</code></p><p><code>570</code><code>  &lt;/div&gt;</code></p><p><code>571</code><code>          </code></p><p><code>572</code><code>&lt;/header&gt;</code></p><p><code>573</code><code>&lt;section id="taxonomyContainer"&gt;</code></p><p><code>574</code><code>          </code></p><p><code>575</code><code>&lt;script src="/resource/js/taxonomy-browser.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>576</code><code>&lt;div id="taxonomy-browser" class="areas" data-search-url="/plosone/browse"&gt;</code></p><p><code>577</code><code>  &lt;div class="wrapper"&gt;</code></p><p><code>578</code><code>    &lt;div class="taxonomy-header"&gt;</code></p><p><code>579</code><code>      Browse Subject Areas</code></p><p><code>580</code><code>      &lt;div id="subjInfo"&gt;?&lt;/div&gt;</code></p><p><code>581</code><code>      &lt;div id="subjInfoText"&gt;</code></p><p><code>582</code><code>        &lt;p&gt;Click through the PLOS taxonomy to find articles in your field.&lt;/p&gt;</code></p><p><code>583</code><code>        &lt;p&gt;For more information about PLOS Subject Areas, click</code></p><p><code>584</code><code>          &lt;a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window"&gt;here&lt;/a&gt;.</code></p><p><code>585</code><code>        &lt;/p&gt;</code></p><p><code>586</code><code>      &lt;/div&gt;</code></p><p><code>587</code><code>    &lt;/div&gt;</code></p><p><code>588</code><code>    &lt;div class="levels"&gt;</code></p><p><code>589</code><code>      &lt;div class="levels-container cf"&gt;</code></p><p><code>590</code><code>        &lt;div class="levels-position"&gt;&lt;/div&gt;</code></p><p><code>591</code><code>      &lt;/div&gt;</code></p><p><code>592</code><code>      &lt;a href="#" class="prev"&gt;&lt;/a&gt;</code></p><p><code>593</code><code>      &lt;a href="#" class="next active"&gt;&lt;/a&gt;</code></p><p><code>594</code><code>    &lt;/div&gt;</code></p><p><code>595</code><code>  &lt;/div&gt;</code></p><p><code>596</code><code>  &lt;div class="taxonomy-browser-border-bottom"&gt;&lt;/div&gt;</code></p><p><code>597</code><code>&lt;/div&gt;</code></p><p><code>598</code><code>&lt;/section&gt;</code></p><p><code>599</code><code>&lt;main id="main-content"&gt; &lt;div class="set-grid"&gt;</code></p><p><code>600</code><code>          </code></p><p><code>601</code><code>&lt;header class="title-block"&gt;</code></p><p><code>602</code><code>          </code></p><p><code>603</code><code>          </code></p><p><code>604</code><code>          </code></p><p><code>605</code><code>&lt;script src="/resource/js/components/signposts.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>606</code><code>          </code></p><p><code>607</code><code>&lt;ul id="almSignposts" class="signposts"&gt;</code></p><p><code>608</code><code>  &lt;li id="loadingMetrics"&gt;</code></p><p><code>609</code><code>    &lt;p&gt;Loading metrics&lt;/p&gt;</code></p><p><code>610</code><code>  &lt;/li&gt;</code></p><p><code>611</code><code>&lt;/ul&gt;</code></p><p><code>612</code><code>          </code></p><p><code>613</code><code>&lt;script type="text/template" id="signpostsGeneralErrorTemplate"&gt;</code></p><p><code>614</code><code>  &lt;li id="metricsError"&gt;Article metrics are unavailable at this time. Please try again later.&lt;/li&gt;</code></p><p><code>615</code><code>&lt;/script&gt;</code></p><p><code>616</code><code>          </code></p><p><code>617</code><code>&lt;script type="text/template" id="signpostsNewArticleErrorTemplate"&gt;</code></p><p><code>618</code><code>  &lt;li&gt;&lt;/li&gt;&lt;li&gt;&lt;/li&gt;&lt;li id="tooSoon"&gt;Article metrics are unavailable for recently published articles.&lt;/li&gt;</code></p><p><code>619</code><code>&lt;/script&gt;</code></p><p><code>620</code><code>          </code></p><p><code>621</code><code>&lt;script type="text/template" id="signpostsTemplate"&gt;</code></p><p><code>622</code><code>    &lt;li id="almSaves"&gt;</code></p><p><code>623</code><code>      &lt;%= s.numberFormat(saveCount, 0) %&gt;</code></p><p><code>624</code><code>      &lt;div class="tools" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>625</code><code>        &lt;a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#savedHeader"&gt;Save&lt;/a&gt;</code></p><p><code>626</code><code>        &lt;p class="saves-tip" data-js-tooltip-hover="target"&gt;&lt;a href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#savedHeader"&gt;Total Mendeley and Citeulike bookmarks.&lt;/a&gt;&lt;/p&gt;</code></p><p><code>627</code><code>      &lt;/div&gt;</code></p><p><code>628</code><code>    &lt;/li&gt;</code></p><p><code>629</code><code>          </code></p><p><code>630</code><code>    &lt;li id="almCitations"&gt;</code></p><p><code>631</code><code>      &lt;%= s.numberFormat(citationCount, 0) %&gt;</code></p><p><code>632</code><code>      &lt;div class="tools" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>633</code><code>        &lt;a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#citedHeader"&gt;Citation&lt;/a&gt;</code></p><p><code>634</code><code>        &lt;p class="citations-tip" data-js-tooltip-hover="target"&gt;&lt;a href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#citedHeader"&gt;Paper's citation count computed by Dimensions.&lt;/a&gt;&lt;/p&gt;</code></p><p><code>635</code><code>      &lt;/div&gt;</code></p><p><code>636</code><code>    &lt;/li&gt;</code></p><p><code>637</code><code>          </code></p><p><code>638</code><code>    &lt;li id="almViews"&gt;</code></p><p><code>639</code><code>      &lt;%= s.numberFormat(viewCount, 0) %&gt;</code></p><p><code>640</code><code>      &lt;div class="tools" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>641</code><code>        &lt;a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#viewedHeader"&gt;View&lt;/a&gt;</code></p><p><code>642</code><code>        &lt;p class="views-tip" data-js-tooltip-hover="target"&gt;&lt;a href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#viewedHeader"&gt;PLOS views and downloads.&lt;/a&gt;&lt;/p&gt;</code></p><p><code>643</code><code>      &lt;/div&gt;</code></p><p><code>644</code><code>    &lt;/li&gt;</code></p><p><code>645</code><code>          </code></p><p><code>646</code><code>    &lt;li id="almShares"&gt;</code></p><p><code>647</code><code>      &lt;%= s.numberFormat(shareCount, 0) %&gt;</code></p><p><code>648</code><code>      &lt;div class="tools" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>649</code><code>        &lt;a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#discussedHeader"&gt;Share&lt;/a&gt;</code></p><p><code>650</code><code>        &lt;p class="shares-tip" data-js-tooltip-hover="target"&gt;&lt;a href="/plosone/article/metrics?id=10.1371/journal.pone.0035569#discussedHeader"&gt;Sum of Facebook, Twitter, Reddit and Wikipedia activity.&lt;/a&gt;&lt;/p&gt;</code></p><p><code>651</code><code>      &lt;/div&gt;</code></p><p><code>652</code><code>    &lt;/li&gt;</code></p><p><code>653</code><code>&lt;/script&gt;</code></p><p><code>654</code><code>          </code></p><p><code>655</code><code>    &lt;div class="article-meta"&gt;</code></p><p><code>656</code><code>          </code></p><p><code>657</code><code>&lt;div class="classifications"&gt;</code></p><p><code>658</code><code>  &lt;p class="license-short" id="licenseShort"&gt;Open Access&lt;/p&gt;</code></p><p><code>659</code><code>  &lt;p class="peer-reviewed" id="peerReviewed"&gt;Peer-reviewed&lt;/p&gt;</code></p><p><code>660</code><code>          </code></p><p><code>661</code><code>&lt;div class="article-type" &gt;</code></p><p><code>662</code><code>  &lt;p class="type-article" id="artType"&gt;Research Article&lt;/p&gt;</code></p><p><code>663</code><code>&lt;/div&gt;</code></p><p><code>664</code><code>          </code></p><p><code>665</code><code>          </code></p><p><code>666</code><code>&lt;/div&gt;</code></p><p><code>667</code><code>    &lt;/div&gt;</code></p><p><code>668</code><code>    &lt;div class="article-title-etc"&gt;</code></p><p><code>669</code><code>          </code></p><p><code>670</code><code>          </code></p><p><code>671</code><code>          </code></p><p><code>672</code><code>&lt;div class="title-authors"&gt;</code></p><p><code>673</code><code>  &lt;h1 id="artTitle"&gt;&lt;?xml version="1.0" encoding="UTF-8"?&gt;Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer&lt;/h1&gt;</code></p><p><code>674</code><code>          </code></p><p><code>675</code><code>&lt;ul class="author-list clearfix"  data-js-tooltip="tooltip_container" id="author-list"&gt;</code></p><p><code>676</code><code>          </code></p><p><code>677</code><code>          </code></p><p><code>678</code><code>          </code></p><p><code>679</code><code>&lt;li</code></p><p><code>680</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>681</code><code>  </code></p><p><code>682</code><code>&gt;</code></p><p><code>683</code><code>   &lt;a  data-author-id="0" class="author-name" &gt;</code></p><p><code>684</code><code>Ryung S. Kim,&lt;/a&gt;    &lt;div id="author-meta-0" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>685</code><code>          </code></p><p><code>686</code><code>  </code></p><p><code>687</code><code>  </code></p><p><code>688</code><code>  &lt;p id="authAffiliations-0"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>689</code><code>    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, United States of America</code></p><p><code>690</code><code>  &lt;/p&gt;</code></p><p><code>691</code><code>          </code></p><p><code>692</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose0"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>693</code><code>    &lt;/div&gt;</code></p><p><code>694</code><code>&lt;/li&gt;</code></p><p><code>695</code><code>          </code></p><p><code>696</code><code>&lt;li</code></p><p><code>697</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>698</code><code>  </code></p><p><code>699</code><code>&gt;</code></p><p><code>700</code><code>   &lt;a  data-author-id="1" class="author-name" &gt;</code></p><p><code>701</code><code>Alvaro Avivar-Valderas,&lt;/a&gt;    &lt;div id="author-meta-1" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>702</code><code>          </code></p><p><code>703</code><code>  </code></p><p><code>704</code><code>  </code></p><p><code>705</code><code>  &lt;p id="authAffiliations-1"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>706</code><code>    Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America</code></p><p><code>707</code><code>  &lt;/p&gt;</code></p><p><code>708</code><code>          </code></p><p><code>709</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose1"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>710</code><code>    &lt;/div&gt;</code></p><p><code>711</code><code>&lt;/li&gt;</code></p><p><code>712</code><code>          </code></p><p><code>713</code><code>&lt;li</code></p><p><code>714</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>715</code><code>  </code></p><p><code>716</code><code>&gt;</code></p><p><code>717</code><code>   &lt;a  data-author-id="2" class="author-name" &gt;</code></p><p><code>718</code><code>Yeriel Estrada,&lt;/a&gt;    &lt;div id="author-meta-2" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>719</code><code>          </code></p><p><code>720</code><code>  </code></p><p><code>721</code><code>  </code></p><p><code>722</code><code>  &lt;p id="authAffiliations-2"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>723</code><code>    Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America</code></p><p><code>724</code><code>  &lt;/p&gt;</code></p><p><code>725</code><code>          </code></p><p><code>726</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose2"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>727</code><code>    &lt;/div&gt;</code></p><p><code>728</code><code>&lt;/li&gt;</code></p><p><code>729</code><code>          </code></p><p><code>730</code><code>&lt;li</code></p><p><code>731</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>732</code><code>  </code></p><p><code>733</code><code>&gt;</code></p><p><code>734</code><code>   &lt;a  data-author-id="3" class="author-name" &gt;</code></p><p><code>735</code><code>Paloma Bragado,&lt;/a&gt;    &lt;div id="author-meta-3" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>736</code><code>          </code></p><p><code>737</code><code>  </code></p><p><code>738</code><code>  </code></p><p><code>739</code><code>  &lt;p id="authAffiliations-3"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>740</code><code>    Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America</code></p><p><code>741</code><code>  &lt;/p&gt;</code></p><p><code>742</code><code>          </code></p><p><code>743</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose3"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>744</code><code>    &lt;/div&gt;</code></p><p><code>745</code><code>&lt;/li&gt;</code></p><p><code>746</code><code>          </code></p><p><code>747</code><code>&lt;li</code></p><p><code>748</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>749</code><code>  </code></p><p><code>750</code><code>&gt;</code></p><p><code>751</code><code>   &lt;a  data-author-id="4" class="author-name" &gt;</code></p><p><code>752</code><code>Maria Soledad Sosa,&lt;/a&gt;    &lt;div id="author-meta-4" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>753</code><code>          </code></p><p><code>754</code><code>  </code></p><p><code>755</code><code>  </code></p><p><code>756</code><code>  &lt;p id="authAffiliations-4"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>757</code><code>    Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America</code></p><p><code>758</code><code>  &lt;/p&gt;</code></p><p><code>759</code><code>          </code></p><p><code>760</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose4"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>761</code><code>    &lt;/div&gt;</code></p><p><code>762</code><code>&lt;/li&gt;</code></p><p><code>763</code><code>          </code></p><p><code>764</code><code>&lt;li</code></p><p><code>765</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>766</code><code>  </code></p><p><code>767</code><code>&gt;</code></p><p><code>768</code><code>   &lt;a  data-author-id="5" class="author-name" &gt;</code></p><p><code>769</code><code>Julio A. Aguirre-Ghiso &lt;span class="email"&gt;  &lt;/span&gt;,&lt;/a&gt;    &lt;div id="author-meta-5" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>770</code><code>          </code></p><p><code>771</code><code>  </code></p><p><code>772</code><code>  &lt;p id="authCorresponding-5"&gt; &lt;span class="email"&gt;* E-mail:&lt;/span&gt; &lt;a href="mailto:julio.aguirre-ghiso@mssm.edu"&gt;julio.aguirre-ghiso@mssm.edu&lt;/a&gt; (J.A.A.-G.); &lt;a href="mailto:jeffrey.segall@einstein.yu.edu"&gt;jeffrey.segall@einstein.yu.edu&lt;/a&gt; (J.E.S.)&lt;/p&gt;</code></p><p><code>773</code><code>  &lt;p id="authAffiliations-5"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>774</code><code>    Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America</code></p><p><code>775</code><code>  &lt;/p&gt;</code></p><p><code>776</code><code>          </code></p><p><code>777</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose5"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>778</code><code>    &lt;/div&gt;</code></p><p><code>779</code><code>&lt;/li&gt;</code></p><p><code>780</code><code>          </code></p><p><code>781</code><code>&lt;li</code></p><p><code>782</code><code>  data-js-tooltip="tooltip_trigger"</code></p><p><code>783</code><code>  </code></p><p><code>784</code><code>&gt;</code></p><p><code>785</code><code>   &lt;a  data-author-id="6" class="author-name" &gt;</code></p><p><code>786</code><code>Jeffrey E. Segall &lt;span class="email"&gt;  &lt;/span&gt;&lt;/a&gt;    &lt;div id="author-meta-6" class="author-info" data-js-tooltip="tooltip_target"&gt;</code></p><p><code>787</code><code>          </code></p><p><code>788</code><code>  </code></p><p><code>789</code><code>  &lt;p id="authCorresponding-6"&gt; &lt;span class="email"&gt;* E-mail:&lt;/span&gt; &lt;a href="mailto:julio.aguirre-ghiso@mssm.edu"&gt;julio.aguirre-ghiso@mssm.edu&lt;/a&gt; (J.A.A.-G.); &lt;a href="mailto:jeffrey.segall@einstein.yu.edu"&gt;jeffrey.segall@einstein.yu.edu&lt;/a&gt; (J.E.S.)&lt;/p&gt;</code></p><p><code>790</code><code>  &lt;p id="authAffiliations-6"&gt;&lt;span class="type"&gt;Affiliation&lt;/span&gt;</code></p><p><code>791</code><code>    Department of Anatomy and Structural Biology and the Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, United States of America</code></p><p><code>792</code><code>  &lt;/p&gt;</code></p><p><code>793</code><code>          </code></p><p><code>794</code><code>      &lt;a data-js-tooltip="tooltip_close" class="close" id="tooltipClose6"&gt; &amp;#x02A2F; &lt;/a&gt;</code></p><p><code>795</code><code>    &lt;/div&gt;</code></p><p><code>796</code><code>&lt;/li&gt;</code></p><p><code>797</code><code>          </code></p><p><code>798</code><code>&lt;/ul&gt;</code></p><p><code>799</code><code>&lt;script src="/resource/js/components/tooltip.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>800</code><code>          </code></p><p><code>801</code><code>&lt;/div&gt;</code></p><p><code>802</code><code>          </code></p><p><code>803</code><code>          </code></p><p><code>804</code><code>&lt;div id="floatTitleTop" data-js-floater="title_author" class="float-title" role="presentation"&gt;</code></p><p><code>805</code><code>  &lt;div class="set-grid"&gt;</code></p><p><code>806</code><code>    &lt;div class="float-title-inner"&gt;</code></p><p><code>807</code><code>      &lt;h1&gt;&lt;?xml version="1.0" encoding="UTF-8"?&gt;Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer&lt;/h1&gt;</code></p><p><code>808</code><code>          </code></p><p><code>809</code><code>&lt;ul id="floatAuthorList" data-js-floater="floated_authors"&gt;</code></p><p><code>810</code><code>          </code></p><p><code>811</code><code>  &lt;li data-float-index="1"&gt;Ryung S. Kim,&amp;nbsp;</code></p><p><code>812</code><code>          </code></p><p><code>813</code><code>  &lt;/li&gt;</code></p><p><code>814</code><code>  &lt;li data-float-index="2"&gt;Alvaro Avivar-Valderas,&amp;nbsp;</code></p><p><code>815</code><code>          </code></p><p><code>816</code><code>  &lt;/li&gt;</code></p><p><code>817</code><code>  &lt;li data-float-index="3"&gt;Yeriel Estrada,&amp;nbsp;</code></p><p><code>818</code><code>          </code></p><p><code>819</code><code>  &lt;/li&gt;</code></p><p><code>820</code><code>  &lt;li data-float-index="4"&gt;Paloma Bragado,&amp;nbsp;</code></p><p><code>821</code><code>          </code></p><p><code>822</code><code>  &lt;/li&gt;</code></p><p><code>823</code><code>  &lt;li data-float-index="5"&gt;Maria Soledad Sosa,&amp;nbsp;</code></p><p><code>824</code><code>          </code></p><p><code>825</code><code>  &lt;/li&gt;</code></p><p><code>826</code><code>  &lt;li data-float-index="6"&gt;Julio A. Aguirre-Ghiso,&amp;nbsp;</code></p><p><code>827</code><code>          </code></p><p><code>828</code><code>  &lt;/li&gt;</code></p><p><code>829</code><code>  &lt;li data-float-index="7"&gt;Jeffrey E. Segall</code></p><p><code>830</code><code>          </code></p><p><code>831</code><code>  &lt;/li&gt;</code></p><p><code>832</code><code>          </code></p><p><code>833</code><code>&lt;/ul&gt;</code></p><p><code>834</code><code>          </code></p><p><code>835</code><code>          </code></p><p><code>836</code><code>          </code></p><p><code>837</code><code>    &lt;/div&gt;</code></p><p><code>838</code><code>    &lt;div class="logo-close" id="titleTopCloser"&gt;</code></p><p><code>839</code><code>      &lt;img src="/resource/img/logo-plos.png" style="height: 2em" alt="PLOS" /&gt;</code></p><p><code>840</code><code>      &lt;div class="close-floater" title="close"&gt;x&lt;/div&gt;</code></p><p><code>841</code><code>    &lt;/div&gt;</code></p><p><code>842</code><code>  &lt;/div&gt;</code></p><p><code>843</code><code>&lt;/div&gt;</code></p><p><code>844</code><code>          </code></p><p><code>845</code><code>      &lt;ul class="date-doi"&gt;</code></p><p><code>846</code><code>        &lt;li id="artPubDate"&gt;Published: April 18, 2012&lt;/li&gt;</code></p><p><code>847</code><code>        &lt;li id="artDoi"&gt;</code></p><p><code>848</code><code>&lt;a   href="https://doi.org/10.1371/journal.pone.0035569"&gt;https://doi.org/10.1371/journal.pone.0035569&lt;/a&gt;</code></p><p><code>849</code><code>        &lt;/li&gt;</code></p><p><code>850</code><code>        &lt;li class="flex-spacer"&gt;&lt;/li&gt;</code></p><p><code>851</code><code>      &lt;/ul&gt;</code></p><p><code>852</code><code>          </code></p><p><code>853</code><code>    &lt;/div&gt;</code></p><p><code>854</code><code>  &lt;div&gt;</code></p><p><code>855</code><code>          </code></p><p><code>856</code><code>  &lt;/div&gt;</code></p><p><code>857</code><code>&lt;/header&gt;</code></p><p><code>858</code><code>  &lt;section class="article-body"&gt;</code></p><p><code>859</code><code>          </code></p><p><code>860</code><code>          </code></p><p><code>861</code><code>          </code></p><p><code>862</code><code>&lt;ul class="article-tabs"&gt;</code></p><p><code>863</code><code>          </code></p><p><code>864</code><code>          &lt;li class="tab-title active" id="tabArticle"&gt;</code></p><p><code>865</code><code>            &lt;a href="/plosone/article?id=10.1371/journal.pone.0035569" class="article-tab-1"&gt;Article&lt;/a&gt;</code></p><p><code>866</code><code>        &lt;/li&gt;</code></p><p><code>867</code><code>          </code></p><p><code>868</code><code>          </code></p><p><code>869</code><code>              &lt;li class="tab-title " id="tabAuthors"&gt;</code></p><p><code>870</code><code>            &lt;a href="/plosone/article/authors?id=10.1371/journal.pone.0035569" class="article-tab-2"&gt;Authors&lt;/a&gt;</code></p><p><code>871</code><code>        &lt;/li&gt;</code></p><p><code>872</code><code>          </code></p><p><code>873</code><code>          </code></p><p><code>874</code><code>          &lt;li class="tab-title " id="tabMetrics"&gt;</code></p><p><code>875</code><code>            &lt;a href="/plosone/article/metrics?id=10.1371/journal.pone.0035569" class="article-tab-3"&gt;Metrics&lt;/a&gt;</code></p><p><code>876</code><code>        &lt;/li&gt;</code></p><p><code>877</code><code>          </code></p><p><code>878</code><code>          </code></p><p><code>879</code><code>          &lt;li class="tab-title " id="tabComments"&gt;</code></p><p><code>880</code><code>            &lt;a href="/plosone/article/comments?id=10.1371/journal.pone.0035569" class="article-tab-4"&gt;Comments&lt;/a&gt;</code></p><p><code>881</code><code>        &lt;/li&gt;</code></p><p><code>882</code><code>          </code></p><p><code>883</code><code>  &lt;li class="tab-title" id="tabRelated"&gt;</code></p><p><code>884</code><code>    &lt;a class="article-tab-5" id="tabRelated-link"&gt;Media Coverage&lt;/a&gt; </code></p><p><code>885</code><code>    &lt;script&gt;$(document).ready(function() { $.getMediaLink("10.1371/journal.pone.0035569").then(function (url) { $("#tabRelated-link").attr("href", url) } ) })&lt;/script&gt;</code></p><p><code>886</code><code>  &lt;/li&gt;</code></p><p><code>887</code><code>&lt;/ul&gt;</code></p><p><code>888</code><code>          </code></p><p><code>889</code><code>    &lt;div class="article-container"&gt;</code></p><p><code>890</code><code>          </code></p><p><code>891</code><code>          </code></p><p><code>892</code><code>&lt;div id="nav-article"&gt;</code></p><p><code>893</code><code>  &lt;ul class="nav-secondary"&gt;</code></p><p><code>894</code><code>          </code></p><p><code>895</code><code>    &lt;li class="nav-comments" id="nav-comments"&gt;</code></p><p><code>896</code><code>      &lt;a href="article/comments?id=10.1371/journal.pone.0035569"&gt;Reader Comments&lt;/a&gt;</code></p><p><code>897</code><code>    &lt;/li&gt;</code></p><p><code>898</code><code>          </code></p><p><code>899</code><code>    &lt;li id="nav-figures"&gt;&lt;a href="#" data-doi="10.1371/journal.pone.0035569"&gt;Figures&lt;/a&gt;&lt;/li&gt;</code></p><p><code>900</code><code>  &lt;/ul&gt;</code></p><p><code>901</code><code>  &lt;div id="nav-data-linking" data-data-url=""&gt;</code></p><p><code>902</code><code>  &lt;/div&gt;</code></p><p><code>903</code><code>&lt;/div&gt;</code></p><p><code>904</code><code>&lt;script src="/resource/js/components/scroll.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>905</code><code>&lt;script src="/resource/js/components/nav_builder.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>906</code><code>&lt;script src="/resource/js/components/floating_nav.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>907</code><code>          </code></p><p><code>908</code><code>&lt;div id="figure-lightbox-container"&gt;&lt;/div&gt;</code></p><p><code>909</code><code>          </code></p><p><code>910</code><code>&lt;script id="figure-lightbox-template" type="text/template"&gt;</code></p><p><code>911</code><code>  &lt;div id="figure-lightbox" class="reveal-modal full" data-reveal aria-hidden="true"</code></p><p><code>912</code><code>       role="dialog"&gt;</code></p><p><code>913</code><code>    &lt;div class="lb-header"&gt;</code></p><p><code>914</code><code>      &lt;h1 id="lb-title"&gt;&lt;%= articleTitle %&gt;&lt;/h1&gt;</code></p><p><code>915</code><code>          </code></p><p><code>916</code><code>      &lt;div id="lb-authors"&gt;</code></p><p><code>917</code><code>              &lt;span&gt;Ryung S. Kim&lt;/span&gt;</code></p><p><code>918</code><code>              &lt;span&gt;Alvaro Avivar-Valderas&lt;/span&gt;</code></p><p><code>919</code><code>          &lt;a class="more-authors" href="/plosone/article/authors?id=10.1371/journal.pone.0035569"&gt;...&lt;/a&gt;</code></p><p><code>920</code><code>          &lt;span&gt;Jeffrey E. Segall&lt;/span&gt;</code></p><p><code>921</code><code>      &lt;/div&gt;</code></p><p><code>922</code><code>          </code></p><p><code>923</code><code>      &lt;div class="lb-close" title="close"&gt;&amp;nbsp;&lt;/div&gt;</code></p><p><code>924</code><code>    &lt;/div&gt;</code></p><p><code>925</code><code>    &lt;div class="img-container"&gt;</code></p><p><code>926</code><code>      &lt;div class="loader"&gt; &lt;i class="fa-spinner"&gt;&lt;/i&gt; &lt;/div&gt;</code></p><p><code>927</code><code>      &lt;img class="main-lightbox-image" src=""/&gt;</code></p><p><code>928</code><code>      &lt;aside id="figures-list"&gt;</code></p><p><code>929</code><code>        &lt;% figureList.each(function (ix, figure) { %&gt;</code></p><p><code>930</code><code>        &lt;div class="change-img" data-doi="&lt;%= figure.getAttribute('data-doi') %&gt;"&gt;</code></p><p><code>931</code><code>          &lt;img class="aside-figure" src="/plosone/article/figure/image?size=inline&amp;id=&lt;%= figure.getAttribute('data-doi') %&gt;" /&gt;</code></p><p><code>932</code><code>        &lt;/div&gt;</code></p><p><code>933</code><code>        &lt;% }) %&gt;</code></p><p><code>934</code><code>        &lt;div class="dummy-figure"&gt;</code></p><p><code>935</code><code>        &lt;/div&gt;</code></p><p><code>936</code><code>      &lt;/aside&gt;</code></p><p><code>937</code><code>    &lt;/div&gt;</code></p><p><code>938</code><code>    &lt;div id="lightbox-footer"&gt;</code></p><p><code>939</code><code>          </code></p><p><code>940</code><code>      &lt;div id="btns-container" class="lightbox-row &lt;% if(figureList.length &lt;= 1) { print('one-figure-only') } %&gt;"&gt;</code></p><p><code>941</code><code>        &lt;div class="fig-btns-container reset-zoom-wrapper left"&gt;</code></p><p><code>942</code><code>          &lt;span class="fig-btn reset-zoom-btn"&gt;Reset zoom&lt;/span&gt;</code></p><p><code>943</code><code>        &lt;/div&gt;</code></p><p><code>944</code><code>        &lt;div class="zoom-slider-container"&gt;</code></p><p><code>945</code><code>          &lt;div class="range-slider-container"&gt;</code></p><p><code>946</code><code>            &lt;span id="lb-zoom-min"&gt;&lt;/span&gt;</code></p><p><code>947</code><code>            &lt;div class="range-slider round" data-slider data-options="start: 20; end: 200; initial: 20;"&gt;</code></p><p><code>948</code><code>              &lt;span class="range-slider-handle" role="slider" tabindex="0"&gt;&lt;/span&gt;</code></p><p><code>949</code><code>              &lt;span class="range-slider-active-segment"&gt;&lt;/span&gt;</code></p><p><code>950</code><code>              &lt;input type="hidden"&gt;</code></p><p><code>951</code><code>            &lt;/div&gt;</code></p><p><code>952</code><code>            &lt;span id="lb-zoom-max"&gt;&lt;/span&gt;</code></p><p><code>953</code><code>          &lt;/div&gt;</code></p><p><code>954</code><code>        &lt;/div&gt;</code></p><p><code>955</code><code>        &lt;% if(figureList.length &gt; 1) { %&gt;</code></p><p><code>956</code><code>        &lt;div class="fig-btns-container"&gt;</code></p><p><code>957</code><code>          &lt;span class="fig-btn all-fig-btn"&gt;&lt;i class="icon icon-all"&gt;&lt;/i&gt; All Figures&lt;/span&gt;</code></p><p><code>958</code><code>          &lt;span class="fig-btn next-fig-btn"&gt;&lt;i class="icon icon-next"&gt;&lt;/i&gt; Next&lt;/span&gt;</code></p><p><code>959</code><code>          &lt;span class="fig-btn prev-fig-btn"&gt;&lt;i class="icon icon-prev"&gt;&lt;/i&gt; Previous&lt;/span&gt;</code></p><p><code>960</code><code>        &lt;/div&gt;</code></p><p><code>961</code><code>        &lt;% } %&gt;</code></p><p><code>962</code><code>      &lt;/div&gt;</code></p><p><code>963</code><code>      &lt;div id="image-context"&gt;</code></p><p><code>964</code><code>      &lt;/div&gt;</code></p><p><code>965</code><code>    &lt;/div&gt;</code></p><p><code>966</code><code>  &lt;/div&gt;</code></p><p><code>967</code><code>&lt;/script&gt;</code></p><p><code>968</code><code>          </code></p><p><code>969</code><code>&lt;script id="image-context-template" type="text/template"&gt;</code></p><p><code>970</code><code>  &lt;div class="footer-text"&gt;</code></p><p><code>971</code><code>    &lt;div id="figure-description-wrapper"&gt;</code></p><p><code>972</code><code>      &lt;div id="view-more-wrapper" style="&lt;% descriptionExpanded? print('display:none;') : '' %&gt;"&gt;</code></p><p><code>973</code><code>        &lt;span id="figure-title"&gt;&lt;%= title %&gt;&lt;/span&gt;</code></p><p><code>974</code><code>        &lt;p id="figure-description"&gt;</code></p><p><code>975</code><code>          &lt;%= description %&gt;&amp;nbsp;&amp;nbsp;</code></p><p><code>976</code><code>        &lt;/p&gt;</code></p><p><code>977</code><code>        &lt;span id="view-more"&gt;show more&lt;i class="icon-arrow-right"&gt;&lt;/i&gt;&lt;/span&gt;</code></p><p><code>978</code><code>          </code></p><p><code>979</code><code>      &lt;/div&gt;</code></p><p><code>980</code><code>      &lt;div id="view-less-wrapper" style="&lt;% descriptionExpanded? print('display:inline-block;') : '' %&gt;" &gt;</code></p><p><code>981</code><code>        &lt;span id="figure-title"&gt;&lt;%= title %&gt;&lt;/span&gt;</code></p><p><code>982</code><code>        &lt;p id="full-figure-description"&gt;</code></p><p><code>983</code><code>          &lt;%= description %&gt;&amp;nbsp;&amp;nbsp;</code></p><p><code>984</code><code>          &lt;span id="view-less"&gt;show less&lt;i class="icon-arrow-left"&gt;&lt;/i&gt;&lt;/span&gt;</code></p><p><code>985</code><code>        &lt;/p&gt;</code></p><p><code>986</code><code>      &lt;/div&gt;</code></p><p><code>987</code><code>    &lt;/div&gt;</code></p><p><code>988</code><code>  &lt;/div&gt;</code></p><p><code>989</code><code>  &lt;div id="show-context-container"&gt;</code></p><p><code>990</code><code>    &lt;a class="btn show-context" href="&lt;%= showInContext(strippedDoi) %&gt;"&gt;Show in Context&lt;/a&gt;</code></p><p><code>991</code><code>  &lt;/div&gt;</code></p><p><code>992</code><code>  &lt;div id="download-buttons"&gt;</code></p><p><code>993</code><code>    &lt;h3&gt;Download:&lt;/h3&gt;</code></p><p><code>994</code><code>    &lt;div class="item"&gt;</code></p><p><code>995</code><code>      &lt;a href="/plosone/article/figure/image?size=original&amp;download=&amp;id=&lt;%= doi %&gt;" title="original image"&gt;</code></p><p><code>996</code><code>        &lt;span class="download-btn"&gt;TIFF&lt;/span&gt;</code></p><p><code>997</code><code>      &lt;/a&gt;</code></p><p><code>998</code><code>      &lt;span class="file-size"&gt;&lt;%= fileSizes.original %&gt;&lt;/span&gt;</code></p><p><code>999</code><code>    &lt;/div&gt;</code></p><p><code>1000</code><code>    &lt;div class="item"&gt;</code></p><p><code>1001</code><code>      &lt;a href="/plosone/article/figure/image?size=large&amp;download=&amp;id=&lt;%= doi %&gt;" title="large image"&gt;</code></p><p><code>1002</code><code>        &lt;span class="download-btn"&gt;PNG&lt;/span&gt;</code></p><p><code>1003</code><code>      &lt;/a&gt;</code></p><p><code>1004</code><code>      &lt;span class="file-size"&gt;&lt;%= fileSizes.large %&gt;&lt;/span&gt;</code></p><p><code>1005</code><code>    &lt;/div&gt;</code></p><p><code>1006</code><code>    &lt;div class="item"&gt;</code></p><p><code>1007</code><code>      &lt;a href="/plosone/article/figure/powerpoint?id=&lt;%= doi %&gt;" title="PowerPoint slide"&gt;</code></p><p><code>1008</code><code>        &lt;span class="download-btn"&gt;PPT&lt;/span&gt;</code></p><p><code>1009</code><code>      &lt;/a&gt;</code></p><p><code>1010</code><code>    &lt;/div&gt;</code></p><p><code>1011</code><code>          </code></p><p><code>1012</code><code>  &lt;/div&gt;</code></p><p><code>1013</code><code>&lt;/script&gt;</code></p><p><code>1014</code><code>      &lt;div class="article-content"&gt;</code></p><p><code>1015</code><code>          </code></p><p><code>1016</code><code>          </code></p><p><code>1017</code><code>          </code></p><p><code>1018</code><code>          </code></p><p><code>1019</code><code>          </code></p><p><code>1020</code><code>          </code></p><p><code>1021</code><code>&lt;div id="figure-carousel-section"&gt;</code></p><p><code>1022</code><code>  &lt;h2&gt;Figures&lt;/h2&gt;</code></p><p><code>1023</code><code>          </code></p><p><code>1024</code><code>  &lt;div id="figure-carousel"&gt;</code></p><p><code>1025</code><code>          </code></p><p><code>1026</code><code>    &lt;div class="carousel-wrapper"&gt;</code></p><p><code>1027</code><code>      &lt;div class="slider"&gt;</code></p><p><code>1028</code><code>          </code></p><p><code>1029</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.t001"&gt;</code></p><p><code>1030</code><code>          </code></p><p><code>1031</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t001"</code></p><p><code>1032</code><code>                     loading="lazy"</code></p><p><code>1033</code><code>                     alt="Table 1"</code></p><p><code>1034</code><code>                /&gt;</code></p><p><code>1035</code><code>          </code></p><p><code>1036</code><code>            &lt;/div&gt;</code></p><p><code>1037</code><code>          </code></p><p><code>1038</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.g001"&gt;</code></p><p><code>1039</code><code>          </code></p><p><code>1040</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g001"</code></p><p><code>1041</code><code>                     loading="lazy"</code></p><p><code>1042</code><code>                     alt="Figure 1"</code></p><p><code>1043</code><code>                /&gt;</code></p><p><code>1044</code><code>          </code></p><p><code>1045</code><code>            &lt;/div&gt;</code></p><p><code>1046</code><code>          </code></p><p><code>1047</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.t002"&gt;</code></p><p><code>1048</code><code>          </code></p><p><code>1049</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t002"</code></p><p><code>1050</code><code>                     loading="lazy"</code></p><p><code>1051</code><code>                     alt="Table 2"</code></p><p><code>1052</code><code>                /&gt;</code></p><p><code>1053</code><code>          </code></p><p><code>1054</code><code>            &lt;/div&gt;</code></p><p><code>1055</code><code>          </code></p><p><code>1056</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.g002"&gt;</code></p><p><code>1057</code><code>          </code></p><p><code>1058</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g002"</code></p><p><code>1059</code><code>                     loading="lazy"</code></p><p><code>1060</code><code>                     alt="Figure 2"</code></p><p><code>1061</code><code>                /&gt;</code></p><p><code>1062</code><code>          </code></p><p><code>1063</code><code>            &lt;/div&gt;</code></p><p><code>1064</code><code>          </code></p><p><code>1065</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.t003"&gt;</code></p><p><code>1066</code><code>          </code></p><p><code>1067</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t003"</code></p><p><code>1068</code><code>                     loading="lazy"</code></p><p><code>1069</code><code>                     alt="Table 3"</code></p><p><code>1070</code><code>                /&gt;</code></p><p><code>1071</code><code>          </code></p><p><code>1072</code><code>            &lt;/div&gt;</code></p><p><code>1073</code><code>          </code></p><p><code>1074</code><code>          &lt;div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0035569.g003"&gt;</code></p><p><code>1075</code><code>          </code></p><p><code>1076</code><code>                &lt;img src="/plosone/article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g003"</code></p><p><code>1077</code><code>                     loading="lazy"</code></p><p><code>1078</code><code>                     alt="Figure 3"</code></p><p><code>1079</code><code>                /&gt;</code></p><p><code>1080</code><code>          </code></p><p><code>1081</code><code>            &lt;/div&gt;</code></p><p><code>1082</code><code>      &lt;/div&gt;</code></p><p><code>1083</code><code>    &lt;/div&gt;</code></p><p><code>1084</code><code>          </code></p><p><code>1085</code><code>    &lt;div class="carousel-control"&gt;</code></p><p><code>1086</code><code>      &lt;span class="button previous"&gt;&lt;/span&gt;</code></p><p><code>1087</code><code>      &lt;span class="button next"&gt;&lt;/span&gt;</code></p><p><code>1088</code><code>    &lt;/div&gt;</code></p><p><code>1089</code><code>    &lt;div class="carousel-page-buttons"&gt;</code></p><p><code>1090</code><code>          </code></p><p><code>1091</code><code>    &lt;/div&gt;</code></p><p><code>1092</code><code>  &lt;/div&gt;</code></p><p><code>1093</code><code>&lt;/div&gt;</code></p><p><code>1094</code><code>&lt;script src="/resource/js/vendor/jquery.touchswipe.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1095</code><code>&lt;script src="/resource/js/components/figure_carousel.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1096</code><code>&lt;script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1097</code><code>          </code></p><p><code>1098</code><code>          </code></p><p><code>1099</code><code>        &lt;div class="article-text" id="artText"&gt;</code></p><p><code>1100</code><code>          </code></p><p><code>1101</code><code>          </code></p><p><code>1102</code><code>          </code></p><p><code>1103</code><code>          </code></p><p><code>1104</code><code>&lt;div xmlns:plos="http://plos.org" class="abstract toc-section abstract-type-"&gt;&lt;a id="abstract0" name="abstract0" data-toc="abstract0" class="link-target" title="Abstract"&gt;&lt;/a&gt;&lt;h2&gt;Abstract&lt;/h2&gt;&lt;div class="abstract-content"&gt;&lt;a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and treatment resistance. We generated a dormancy gene signature from published experimental models and applied it to both breast cancer cell line expression data as well as four published clinical studies of primary breast cancers. We found that estrogen receptor (ER) positive breast cell lines and primary tumors have significantly higher dormancy signature scores (P&amp;lt;0.0000001) than ER- cell lines and tumors. In addition, a stratified analysis combining all ER+ tumors in four studies indicated 2.1 times higher hazard of recurrence among patients whose tumors had low dormancy scores (LDS) compared to those whose tumors had high dormancy scores (HDS) (p&amp;lt;0.000005). The trend was shown in all four individual studies. Suppression of two dormancy genes, BHLHE41 and NR2F1, resulted in increased &lt;em&gt;in vivo&lt;/em&gt; growth of ER positive MCF7 cells. The patient data analysis suggests that disseminated ER positive tumor cells carrying a dormancy signature are more likely to undergo prolonged dormancy before resuming metastatic growth. Furthermore, genes identified with this approach might provide insight into the mechanisms of dormancy onset and maintenance as well as dormancy models using human breast cancer cell lines.&lt;/p&gt;</code></p><p><code>1105</code><code>&lt;/div&gt;&lt;/div&gt;</code></p><p><code>1106</code><code>          </code></p><p><code>1107</code><code>          </code></p><p><code>1108</code><code>&lt;div xmlns:plos="http://plos.org" class="articleinfo"&gt;&lt;p&gt;&lt;strong&gt;Citation: &lt;/strong&gt;Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA, et al.  (2012) Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer. PLoS ONE 7(4):</code></p><p><code>1109</code><code>           e35569.</code></p><p><code>1110</code><code>        </code></p><p><code>1111</code><code>        https://doi.org/10.1371/journal.pone.0035569&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Editor: &lt;/strong&gt;John D. Minna, Univesity of Texas Southwestern Medical Center at Dallas, United States of America&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Received: &lt;/strong&gt;December 9, 2010; &lt;strong&gt;Accepted: &lt;/strong&gt;March 21, 2012; &lt;strong&gt;Published: &lt;/strong&gt; April 18, 2012&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Copyright: &lt;/strong&gt; © 2012 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Funding: &lt;/strong&gt;This work is supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program (J.A.A.−G), United States National Institutes of Health/National Cancer Institute (CA109182 and CA163131 to J.A.A.−G, 5P30CA013330-37 to R.K., 1UL1RR025750-0 to R.K., CA77522 and CA1000324 to J.E.S.), NIEHS (ES017146) and NYSTEM to J.A.A.−G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Competing interests: &lt;/strong&gt; The authors have declared that no competing interests exist.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>1112</code><code>          </code></p><p><code>1113</code><code>          </code></p><p><code>1114</code><code>          </code></p><p><code>1115</code><code>          </code></p><p><code>1116</code><code>          </code></p><p><code>1117</code><code>&lt;div xmlns:plos="http://plos.org" id="section1" class="section toc-section"&gt;&lt;a id="s1" name="s1" data-toc="s1" class="link-target" title="Introduction"&gt;&lt;/a&gt;&lt;h2&gt;Introduction&lt;/h2&gt;&lt;a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;The major cause of death from breast cancer is metastasis: the growth of disseminated tumor cells (DTCs) that lodge in distant sites prior to primary tumor surgery. Most successful adjuvant treatments developed to attack DTCs and micrometastases are based on targeting the increased proliferation rate of tumor cells compared to normal cells &lt;a href="#pone.0035569-Naumov1" class="ref-tip"&gt;[1]&lt;/a&gt;. Thus, actively proliferating tumor cells are killed or growth-suppressed by adjuvant treatments. However, non-proliferating, dormant DTCs may remain unscathed. Tumor cell dormancy reflects the capability of DTCs or micrometastases to remain at such low numbers that they are undetected for long periods of time &lt;a href="#pone.0035569-Muller1" class="ref-tip"&gt;[2]&lt;/a&gt;–&lt;a href="#pone.0035569-Vessella1" class="ref-tip"&gt;[5]&lt;/a&gt;. Modeling of dormancy suggests that this could happen through the induction of quiescence, through balanced proliferation and death due to an impaired angiogenic switch or through immune control &lt;a href="#pone.0035569-AguirreGhiso1" class="ref-tip"&gt;[4]&lt;/a&gt;. In this report, we test whether the currently available gene expression signatures for dormancy from experimental models that reflect quiescence and angiogenesis regulation could be used to evaluate breast cancer outcome. We find that the dormancy signature is indeed correlated with clinical parameters. Among ER positive tumors, a higher dormancy score is significantly associated with lower hazard of metastasis.&lt;/p&gt;</code></p><p><code>1118</code><code>&lt;/div&gt;</code></p><p><code>1119</code><code>          </code></p><p><code>1120</code><code>&lt;div xmlns:plos="http://plos.org" id="section2" class="section toc-section"&gt;&lt;a id="s2" name="s2" data-toc="s2" class="link-target" title="Results"&gt;&lt;/a&gt;&lt;h2&gt;Results&lt;/h2&gt;&lt;a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;Models of &lt;em&gt;in vivo&lt;/em&gt; tumor dormancy driven by tumor cell quiescence &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt; or angiogenic failure &lt;a href="#pone.0035569-Almog1" class="ref-tip"&gt;[7]&lt;/a&gt; have identified gene signatures associated with these phenotypes. We hypothesized that these signatures would be helpful in identifying tumors whose disseminated cells would be more prone to undergo dormancy. Based on these expression profiles, we generated a 49-gene signature for tumor cell dormancy (&lt;a href="#pone-0035569-t001"&gt;Table 1&lt;/a&gt;), in which we consider genes upregulated in dormant cells as positive dormancy genes and genes downregulated in dormant cells as negative dormancy genes. For each gene, we scaled the expression intensities by dividing them by their average intensity across samples. Then we defined the dormancy score (see &lt;a href="#s4"&gt;Materials and Methods&lt;/a&gt;) as the difference between the sum of log intensities of the positive dormancy genes and the sum of the log intensities of the negative dormancy genes. All genes were equally weighted in their contributions to the dormancy score. Thus, we set out to determine whether tumors or cell lines that have a higher dormancy score showed any association with clinico-pathological parameters.&lt;/p&gt;</code></p><p><code>1121</code><code>&lt;a class="link-target" id="pone-0035569-t001" name="pone-0035569-t001"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.t001"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.t001" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.t001"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t001" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1122</code><code>          Download:</code></p><p><code>1123</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.t001"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.t001"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.t001"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Table 1. &lt;/span&gt; Dormancy signature genes.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.t001"&gt;</code></p><p><code>1124</code><code>              https://doi.org/10.1371/journal.pone.0035569.t001&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;a id="article1.body1.sec2.p2" name="article1.body1.sec2.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We first applied the dormancy score to published microarray data of 51 breast cancer cell lines grown in tissue culture &lt;a href="#pone.0035569-Neve1" class="ref-tip"&gt;[8]&lt;/a&gt;. We found that ER positive breast cancer cell lines have significantly higher dormancy scores than ER negative ones (p&amp;lt;0.0001; Mann-Whitney test). As a general trend, as the dormancy score increases, the cell line type changes from basal type B to basal type A to luminal (&lt;a href="#pone-0035569-g001"&gt;Figure 1A&lt;/a&gt;). A cluster of 6 positive dormancy genes (STAT3, HIST1H2BK, CTSD, SREBF1, IGFBP5 and DDR1) is more highly expressed in lines with higher dormancy scores. Conversely, a larger cluster of negative dormancy genes is upregulated in lines with lower dormancy scores. Included in this cluster are pro-proliferative genes (NT5E, IL8, PLAT, FOSL1, ODC1). The expression profiles of genes positively correlated with dormancy tended to be less homogeneous compared that of the genes inversely correlated with dormancy (&lt;a href="#pone-0035569-g001"&gt;Figure 1A&lt;/a&gt;). This might be because these expression profiles were obtained from breast cancer cells proliferating in culture while dormancy is mediated by a G0−G1 arrest not achieved in these conditions. Thus, the positive dormancy genes might become more synchronous in their expression &lt;em&gt;in vivo&lt;/em&gt;.&lt;/p&gt;</code></p><p><code>1125</code><code>&lt;a class="link-target" id="pone-0035569-g001" name="pone-0035569-g001"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.g001"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.g001" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.g001"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g001" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1126</code><code>          Download:</code></p><p><code>1127</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.g001"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.g001"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.g001"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Figure 1. &lt;/span&gt; Clustering of dormancy signature scores.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;a id="article1.body1.sec2.fig1.caption1.p1" name="article1.body1.sec2.fig1.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;A) Dormancy score analysis in breast cancer cell lines. The cell lines are ordered by dormancy scores (low to high from left to right). The rows correspond to genes and the columns represent cell lines. Expression levels for positive dormancy genes (upregulated genes - top section) and negative dormancy genes (downregulated genes - bottom section) were clustered by a hierarchical clustering algorithm. The colors represent log&lt;sub&gt;2&lt;/sub&gt; fold change compared to the average from −2.5 (blue, below average) to +2.5 (red, above average) with white as the average value. A, B, and L stand for Basal A, Basal B, and Luminal classifications, respectively. B) Correlation of cell line dormancy scores with proliferation indices from &lt;a href="#pone-0035569-t001"&gt;Table 1&lt;/a&gt; of &lt;a href="#pone.0035569-Kenny1" class="ref-tip"&gt;[9]&lt;/a&gt; with ER- lines plotted as squares and ER+ lines plotted as diamonds. Straight line fits of ER- (blue, Spearman correlation coefficient r = .027) and ER+ (red, r = −0.76) cell lines are plotted. The ER status of HCC1500 is unclear (ATCC indicates it as ER+ while it is ER- by gene expression and Western blot in &lt;a href="#pone.0035569-Neve1" class="ref-tip"&gt;[8]&lt;/a&gt;) and it was not used in the analysis. MDA-MB-231 (large orange square), MCF7 (large green diamond) and T47D (large yellow diamond) are identified. C) Patient tumor analysis. The four clinical studies were clustered as in A. In the ER status bar, ER status is indicated by black (ER+), blue (ER−) or white (not determined) bars. The two genes for which probes were not present in the van de Vijver et al. data set are represented by gray bars. D) Comparison of clustering of cell lines and patient data. Top: Positive dormancy genes that are upregulated in high dormancy score cell lines or patients. Bottom: Negative dormancy genes that are up regulated in low dormancy score cell lines or patients.&lt;/p&gt;</code></p><p><code>1128</code><code>&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.g001"&gt;</code></p><p><code>1129</code><code>              https://doi.org/10.1371/journal.pone.0035569.g001&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;a id="article1.body1.sec2.p3" name="article1.body1.sec2.p3" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;To evaluate &lt;em&gt;in vivo&lt;/em&gt; dormancy properties of these subgroups, GFP labeled MDA-MB-231, MCF7, and T47D cells were labeled with Cell Trace Violet and injected into the mammary fat pads of SCID mice. After 3 days, the retained label and proportions of GFP positive cells were determined by FACS. Label retention was positively correlated with dormancy signature score (Spearman correlation coefficient +0.71, p&amp;lt;.01). The proportion of GFP labeled cells in the mammary fat pad was inversely correlated with dormancy signature score (Spearman coefficient −.857, p&amp;lt;.001), consistent with increased dormancy. We next determined if there was any association between the dormancy score and the inherent proliferative capacity of these cancer cell lines. To this end we compared the dormancy score with published proliferation indices measured in 3D growth conditions available for 22 of the cell lines &lt;a href="#pone.0035569-Kenny1" class="ref-tip"&gt;[9]&lt;/a&gt;. We found that there was no statistically significant correlation between proliferation index and dormancy score for ER- cell lines (p&amp;gt;.9), but a significant correlation for ER+ cell lines (Spearman correlation coefficient −0.76, p&amp;lt;.01, &lt;a href="#pone-0035569-g001"&gt;Figure 1B&lt;/a&gt;). Thus, the dormancy score is indicative of a program that imposes slower growing kinetics on ER+ tumor cells in 3D culture, suggesting that it might be indicative of slow proliferation or quiescence in vivo.&lt;/p&gt;</code></p><p><code>1130</code><code>&lt;a id="article1.body1.sec2.p4" name="article1.body1.sec2.p4" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;To test if the in vivo conditions in patients reveal a similar or better relationship between the dormancy scores and breast cancer progression, we evaluated the dormancy signatures of clinical breast cancer samples. We used four published microarray data sets that included well annotated invasive breast cancers with at least seven years of follow-up &lt;a href="#pone.0035569-Neve1" class="ref-tip"&gt;[8]&lt;/a&gt;, &lt;a href="#pone.0035569-Loi1" class="ref-tip"&gt;[10]&lt;/a&gt;–&lt;a href="#pone.0035569-vandeVijver1" class="ref-tip"&gt;[13]&lt;/a&gt;. We performed an analysis of all the samples in the four studies, stratified by study, and found that the dormancy scores were significantly higher in ER+ tumors compared to ER- tumors (p&amp;lt;0.0000001; stratified Mann-Whitney rank sum test, &lt;a href="#pone-0035569-t002"&gt;Table 2&lt;/a&gt;). This is consistent with our analysis of the breast cancer cell lines. Analysis of the individual studies also showed a significantly higher dormancy score in ER+ vs. ER- tumors in three out of four (p&amp;lt;0.001) while one study &lt;a href="#pone.0035569-Loi1" class="ref-tip"&gt;[10]&lt;/a&gt; showed a weak trend in the same direction (&lt;a href="#pone-0035569-t002"&gt;Table 2&lt;/a&gt;). Thus, although the genes selected for the dormancy score were identified from gene expression patterns of cell lines grown in tissue culture, their predictive value for an &lt;em&gt;in vivo&lt;/em&gt; phenotype in the experimental models &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt;, &lt;a href="#pone.0035569-Almog1" class="ref-tip"&gt;[7]&lt;/a&gt; could be extended to differentiating between primary tumors with different ER status.&lt;/p&gt;</code></p><p><code>1131</code><code>&lt;a class="link-target" id="pone-0035569-t002" name="pone-0035569-t002"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.t002"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.t002" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.t002"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t002" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1132</code><code>          Download:</code></p><p><code>1133</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.t002"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.t002"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.t002"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Table 2. &lt;/span&gt; Dormancy scores of ER positive and ER negative tumors.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.t002"&gt;</code></p><p><code>1134</code><code>              https://doi.org/10.1371/journal.pone.0035569.t002&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;a id="article1.body1.sec2.p5" name="article1.body1.sec2.p5" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;Examination of the clustering of the clinical samples revealed a difference between the positive and negative dormancy genes (&lt;a href="#pone-0035569-g001"&gt;Figure 1C&lt;/a&gt;). The set of negative dormancy genes that was upregulated in the tumors with low dormancy scores was similar to the set that we observed in the cell lines; of the 22 negative dormancy genes that were upregulated in the cell lines with low dormancy scores, 19 were also upregulated in tumors with low dormancy scores, and one additional gene was upregulated in the tumors with low dormancy scores (APEX1). However, there was a more dramatic change in the positive dormancy genes. As noted above, in the cell lines with high dormancy scores there were fewer positive dormancy genes that were upregulated (6), and of those 5 were also upregulated in tumors with high dormancy scores. However, in patient tumors with high dormancy scores there were an additional 12 positive dormancy genes that were upregulated (&lt;a href="#pone-0035569-g001"&gt;Figure 1D&lt;/a&gt;). This indicates that in vivo the positive dormancy genes are more synchronously expressed and this may prime these cells upon dissemination to fully enter a G0–G1 arrest in secondary sites.&lt;/p&gt;</code></p><p><code>1135</code><code>&lt;a id="article1.body1.sec2.p6" name="article1.body1.sec2.p6" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We then tested the association between dormancy and distant metastasis free survival. Time to metastasis was determined as a measure of the persistence of asymptomatic and possibly dormant disease. In all four studies, patients whose ER+ tumors had higher dormancy scores showed significantly or moderately significantly reduced rate of recurrence (&lt;a href="#pone-0035569-t003"&gt;Table 3&lt;/a&gt;). A stratified proportional hazards model combining all ER+ tumors in the four studies indicated 2.1 times higher hazard of metastasis among patients with LDS tumors compared to those with HDS tumors (p&amp;lt;0.000005). Kaplan Meier plots confirmed the correlation of dormancy score with survival for ER+ tumors but not for ER- tumors (&lt;a href="#pone-0035569-g002"&gt;Figure 2&lt;/a&gt;).&lt;/p&gt;</code></p><p><code>1136</code><code>&lt;a class="link-target" id="pone-0035569-g002" name="pone-0035569-g002"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.g002"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.g002" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.g002"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g002" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1137</code><code>          Download:</code></p><p><code>1138</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.g002"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.g002"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.g002"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Figure 2. &lt;/span&gt; Metastasis-free analysis for four clinical studies.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;a id="article1.body1.sec2.fig2.caption1.p1" name="article1.body1.sec2.fig2.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;(A, B) van de Vijver et al., (C, D) Loi et al., (E,F) Wang et al., (G, H) Pawitan et al. Kaplan Meier estimates of metastasis-free proportion among patients with high (upper third, green), medium (middle third, red), and low (bottom third, black) dormancy scores for patients with ER+ (A,C,E,F) and ER− (B,D,F,G) tumors.&lt;/p&gt;</code></p><p><code>1139</code><code>&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.g002"&gt;</code></p><p><code>1140</code><code>              https://doi.org/10.1371/journal.pone.0035569.g002&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;a class="link-target" id="pone-0035569-t003" name="pone-0035569-t003"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.t003"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.t003" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.t003"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.t003" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1141</code><code>          Download:</code></p><p><code>1142</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.t003"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.t003"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.t003"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Table 3. &lt;/span&gt; Hazard ratios of metastasis for ER+ tumors according to dormancy score.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.t003"&gt;</code></p><p><code>1143</code><code>              https://doi.org/10.1371/journal.pone.0035569.t003&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;a id="article1.body1.sec2.p7" name="article1.body1.sec2.p7" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;The data gathered in &lt;a href="#pone-0035569-g001"&gt;Figures 1&lt;/a&gt;and &lt;a href="#pone-0035569-g002"&gt;2&lt;/a&gt; revealed that ER+ luminal type tumor cells carry a dormancy gene signature. We hypothesized that some of these genes might contribute to dormancy of ER+ tumor cells. We have previously shown that both BHLHE41 and NR2F1 are required for or associated with dormancy of squamous carcinoma cells &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt;. Thus, we tested in the ER+ luminal type breast cancer cell line MCF-7 whether knocking down these genes affected latency and subsequent tumor growth. MCF-7 is known to show long latency periods before achieving a high rate of tumor take &lt;a href="#pone.0035569-Klopp1" class="ref-tip"&gt;[14]&lt;/a&gt;. We hypothesized that if these genes were required to maintain dormancy then this phase should be shortened and/or the tumor-take enhanced.&lt;/p&gt;</code></p><p><code>1144</code><code>&lt;a id="article1.body1.sec2.p8" name="article1.body1.sec2.p8" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;MCF-7 cells were transfected for 24 hrs with a control scrambled siRNA or siRNAs targeting NR2F1 or BHLHE41, then injected into the mammary fat pads of female NSG mice (&lt;a href="#pone-0035569-g003"&gt;Figure 3A–B&lt;/a&gt;) with a fraction of the cells used to evaluate mRNA knock down using qPCR (&lt;a href="#pone-0035569-g003"&gt;Figure 3C and D&lt;/a&gt;). The siRNAs caused a&amp;gt;75% reduction in BHLHE41 or NR2F1 mRNA normalized to GAPDH (&lt;a href="#pone-0035569-g003"&gt;Figure 3C and D&lt;/a&gt;). Three days after injection in the fat pad and thereafter the mice were monitored for tumor take. We found that 12 days after tumor cell injection only 40% of the mice injected with control siRNA-treated cells had palpable tumors, while palpable tumors were present in 100% of the mice injected with BHLHE41 or NR2F1 siRNA treated cells (&lt;a href="#pone-0035569-g003"&gt;Figure 3A–B&lt;/a&gt;). Furthermore, the tumors produced by BHLHE41 and NR2F1 siRNA treated MCF-7 cells appeared to proliferate faster; the final tumor volume at day 12 was significantly larger for tumors produced by BHLHE41 and NR2F1 siRNA treated cells compared to those produced by control siRNA treated cells (&lt;a href="#pone-0035569-g003"&gt;Figure 3A–B&lt;/a&gt;). These results demonstrate that the genes identified in the dormancy signature are functional in ER+ luminal breast cancer cell lines in limiting tumor growth, possibly through the induction of a dormant phenotype.&lt;/p&gt;</code></p><p><code>1145</code><code>&lt;a class="link-target" id="pone-0035569-g003" name="pone-0035569-g003"&gt;&lt;/a&gt;&lt;div class="figure" data-doi="10.1371/journal.pone.0035569.g003"&gt;&lt;div class="img-box"&gt;&lt;a title="Click for larger image" href="article/figure/image?size=medium&amp;amp;id=10.1371/journal.pone.0035569.g003" data-doi="10.1371/journal.pone.0035569" data-uri="10.1371/journal.pone.0035569.g003"&gt;&lt;img src="article/figure/image?size=inline&amp;amp;id=10.1371/journal.pone.0035569.g003" alt="thumbnail" class="thumbnail" loading="lazy"&gt;&lt;/a&gt;&lt;div class="expand"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="figure-inline-download"&gt;</code></p><p><code>1146</code><code>          Download:</code></p><p><code>1147</code><code>          &lt;ul&gt;&lt;li&gt;&lt;a href="article/figure/powerpoint?id=10.1371/journal.pone.0035569.g003"&gt;&lt;div class="definition-label"&gt;PPT&lt;/div&gt;&lt;div class="definition-description"&gt;PowerPoint slide&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=large&amp;amp;id=10.1371/journal.pone.0035569.g003"&gt;&lt;div class="definition-label"&gt;PNG&lt;/div&gt;&lt;div class="definition-description"&gt;larger image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="article/figure/image?download&amp;amp;size=original&amp;amp;id=10.1371/journal.pone.0035569.g003"&gt;&lt;div class="definition-label"&gt;TIFF&lt;/div&gt;&lt;div class="definition-description"&gt;original image&lt;/div&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div class="figcaption"&gt;&lt;span&gt;Figure 3. &lt;/span&gt; RNAi suppression of dormancy upregulated genes accelerates tumor take and growth of ER+ luminal MCF-7 cells.&lt;/div&gt;&lt;p class="caption_target"&gt;&lt;a id="article1.body1.sec2.fig3.caption1.p1" name="article1.body1.sec2.fig3.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;(A) Percent of tumor take at the indicated time points after injecting with 4 10&lt;sup&gt;6&lt;/sup&gt; MCF7 cells treated with the indicated siRNAs in the mouse mammary fat pad. (B) Tumor volume (mm&lt;sup&gt;3&lt;/sup&gt;) at 12 days for tumors generated by MCF7 cells treated with the indicated siRNAs and injected in the mouse mammary fat pad. (C–D) Q-PCR analysis for the expression of BHLHE41 (C) and NR2F1 (D) mRNAs after 48 hrs of treatment with control or specific siRNAs targeting these mRNAs.&lt;/p&gt;</code></p><p><code>1148</code><code>&lt;/p&gt;&lt;p class="caption_object"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.g003"&gt;</code></p><p><code>1149</code><code>              https://doi.org/10.1371/journal.pone.0035569.g003&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</code></p><p><code>1150</code><code>          </code></p><p><code>1151</code><code>&lt;div xmlns:plos="http://plos.org" id="section3" class="section toc-section"&gt;&lt;a id="s3" name="s3" data-toc="s3" class="link-target" title="Discussion"&gt;&lt;/a&gt;&lt;h2&gt;Discussion&lt;/h2&gt;&lt;a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We present a dormancy score based on gene signatures developed by combining dormancy expression profiles from a variety of cancer types using even-weighting of all the genes. Although neither recurrence information nor ER status was used to select these genes or to refine the scores, we found that luminal, ER+ breast cancers were more likely to have a high dormancy score. Positive dormancy genes were more synchronously upregulated in patient tumors than in cell lines grown &lt;em&gt;in vitro&lt;/em&gt;, demonstrating the importance of the tumor microenvironment on dormancy properties. Furthermore, the rate of recurrence was significantly reduced for patients whose tumors were ER+ and had a high dormancy score. These results are consistent with the observed clinical outcome that ER+ tumors tend to recur later than ER- tumors &lt;a href="#pone.0035569-Early1" class="ref-tip"&gt;[15]&lt;/a&gt;. Furthermore, since the analysis utilized data from primary tumors, which in some cases came from in patients that underwent mastectomy, the findings suggest that DTCs coming from ER+ tumors with a high dormancy score are more likely to enter a dormancy state.&lt;/p&gt;</code></p><p><code>1152</code><code>&lt;a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We found a correlation between published data on 3D in vitro proliferation indices of ER+ cell lines and dormancy score, with increased dormancy score correlating with reduced 3D proliferation index. However, there was no statistically significant correlation between 3D proliferation index and dormancy score for ER- cell lines. This parallels the patient data, in which the dormancy signature inversely correlates with rate of recurrence for patients with ER+ tumors but not for patients with ER- tumors. This raises the possibility that 3D proliferation index could be used as a surrogate in vitro assay to explore dormancy mechanisms in ER+ tumors, which would then be validated with in vivo assays. It also suggests that dormancy in vivo could reflect a reduced proliferation rate, as evidenced by the frequent lack of proliferation markers in DTCs (Aguirre-Ghiso, 2007). This slow proliferation or quiescence phenotype could explain the presence of non-productive residual disease by limiting the disseminated tumor cell population to a steady state level, potentially complemented by immune attack and limited angiogenesis. Comparing the dormancy scores of luminal A vs luminal B tumors (which have a higher proliferation index &lt;a href="#pone.0035569-Tran1" class="ref-tip"&gt;[16]&lt;/a&gt;) in the van de Vijver and Pawitan datasets is consistent with this possibility: the median dormancy score is significantly lower in the luminal B tumors compared to the luminal A tumors (van de Vijver: p&amp;lt;10&lt;sup&gt;−4&lt;/sup&gt; and Pawitan: p&amp;lt;10&lt;sup&gt;−5&lt;/sup&gt;). Intriguingly, in a meta-analysis of all luminal B tumors from the two datasets, we found 2.6 times lower hazard of metastasis among patients with high dormancy score tumors compared to those with low dormancy scores (p&amp;lt;.04), indicating that the dormancy score has potential value for differentiating between patients within this subtype of tumors.&lt;/p&gt;</code></p><p><code>1153</code><code>&lt;a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;The dormancy signature also incorporates elements of p38 signaling &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt;, and p38-induced quiescence combined with reduced ability to undergo an angiogenic switch might contribute to ER+ tumor cell dormancy. Several genes in the dormancy signature derived from quiescent cells &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt; are regulators of angiogenesis. For example, THBS1 is an angiogenesis inhibitor induced by p38 &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt;, &lt;a href="#pone.0035569-Takekawa1" class="ref-tip"&gt;[17]&lt;/a&gt;, &lt;a href="#pone.0035569-McGillicuddy1" class="ref-tip"&gt;[18]&lt;/a&gt;. It is possible that emergence from prolonged quiescence requires the immediate recruitment of blood vessels to support nascent tumor expansion and that might explain why anti-angiogenic genes are embedded in the quiescence signature. Genes such as BHLHE41 (also referred to as BHLHB3 or Sharp-1), NR2F1 and p53 have been linked to the induction of quiescence in an experimental system &lt;a href="#pone.0035569-Adam1" class="ref-tip"&gt;[6]&lt;/a&gt;. Furthermore, BHLHE41 was independently discovered as a metastasis suppressor gene in breast cancer &lt;a href="#pone.0035569-Adorno1" class="ref-tip"&gt;[19]&lt;/a&gt;. This suggests that these genes might be prevalent transcription factors required for persistent induction of dormancy to suppress metastatic growth. This is further supported by our findings that BHLHE41 or NR2F1 knock down strongly stimulated tumor take and growth of MCF-7 ER+ luminal cancer cell lines during the initial dormancy phase that precedes logarithmic tumor growth.&lt;/p&gt;</code></p><p><code>1154</code><code>&lt;a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;It is interesting to speculate that dormancy signatures might be developed for other breast cancer subtypes such as ER- tumors, and that the genes involved would presumably reflect subtype-specific quiescence mechanisms. Targeted treatments that lead to maintenance of the activity of genes that induce dormancy in a breast cancer subtype might be useful in prolonging quiescence, keeping the disease in a chronic state. Alternatively, inhibition of key survival genes in subtype-specific pathways could attack dormant tumor cells before they resume growth and progression, thereby reducing the risk of recurrence.&lt;/p&gt;</code></p><p><code>1155</code><code>&lt;/div&gt;</code></p><p><code>1156</code><code>          </code></p><p><code>1157</code><code>&lt;div xmlns:plos="http://plos.org" id="section4" class="section toc-section"&gt;&lt;a id="s4" name="s4" data-toc="s4" class="link-target" title="Materials and Methods"&gt;&lt;/a&gt;&lt;h2&gt;Materials and Methods&lt;/h2&gt;</code></p><p><code>1158</code><code>&lt;div id="section1" class="section toc-section"&gt;&lt;a id="s4a" name="s4a" class="link-target" title="Dataset sources"&gt;&lt;/a&gt;</code></p><p><code>1159</code><code>&lt;h3&gt;Dataset sources&lt;/h3&gt;</code></p><p><code>1160</code><code>&lt;a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We downloaded expression data set of 51 breast cancer cell lines and ER status of the cell lines from Neve et al. &lt;a href="#pone.0035569-Neve1" class="ref-tip"&gt;[8]&lt;/a&gt;, in which expression profiles were measured using Affymetrix HG-U133A arrays. We downloaded expression data sets of human breast tumors published by Pawitan et al. (&lt;a href="#pone.0035569-Pawitan1" class="ref-tip"&gt;[12]&lt;/a&gt;, n = 159), Loi et al (&lt;a href="#pone.0035569-Loi1" class="ref-tip"&gt;[10]&lt;/a&gt; n = 327), Wang et al. (&lt;a href="#pone.0035569-Wang1" class="ref-tip"&gt;[11]&lt;/a&gt;, n = 286), and van de Vijver et al. (&lt;a href="#pone.0035569-vandeVijver1" class="ref-tip"&gt;[13]&lt;/a&gt; n = 295). Loi et al, Wang et al, and Pawitan et al. measured expression using Affymetrix HG-U133A and HG-U133B arrays. Van de Vijver et al. measured expression using Agilent cDNA arrays. Dr. Y. Pawitan kindly provided the ER status of the samples in Pawitan et al.&lt;/p&gt;</code></p><p><code>1161</code><code>&lt;/div&gt;</code></p><p><code>1162</code><code>          </code></p><p><code>1163</code><code>&lt;div id="section2" class="section toc-section"&gt;&lt;a id="s4b" name="s4b" class="link-target" title="Preprocessing of microarray data"&gt;&lt;/a&gt;</code></p><p><code>1164</code><code>&lt;h3&gt;Preprocessing of microarray data&lt;/h3&gt;</code></p><p><code>1165</code><code>&lt;a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;For the tumor samples from Pawitan et al., Loi et al., and Wang et al., we obtained CEL files. The DNA-Chip Analyzer was used to normalize all CEL files to the baseline arrays and compute the model-based expression (PM-only model; &lt;a href="#pone.0035569-Li1" class="ref-tip"&gt;[20]&lt;/a&gt;). For the cell lines in Neve et al., we obtained already preprocessed data: the published intensities were in log&lt;sub&gt;2&lt;/sub&gt; scale and we transformed them to linear values before computing the dormancy scores.&lt;/p&gt;</code></p><p><code>1166</code><code>&lt;a id="article1.body1.sec4.sec2.p2" name="article1.body1.sec4.sec2.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;For the tumor samples from van de Vijver et al. &lt;a href="#pone.0035569-vandeVijver1" class="ref-tip"&gt;[13]&lt;/a&gt;, the data are ratios between the intensity of individual samples and the average intensity from a cy-labeled cRNA from individual tumor mixed with the same amount of reverse-color cy-labeled pool that consisted of an equal amount of cRNA from each patient. Published ratios of intensities were in log&lt;sub&gt;10&lt;/sub&gt; scale and we transformed them to linear values before computing the dormancy scores.&lt;/p&gt;</code></p><p><code>1167</code><code>&lt;a id="article1.body1.sec4.sec2.p3" name="article1.body1.sec4.sec2.p3" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;For multiple Affymetrix probe sets that targeted a common gene, we used the ‘_at’ probe set with the highest variation measured by the coefficient of variation. When there were no ‘_at’ probe sets targeting a gene, we retained the ‘_s_at’ probe set with the highest variation. When neither of those probe set types were present for a gene, we retained the probe set with the highest variation.&lt;/p&gt;</code></p><p><code>1168</code><code>&lt;/div&gt;</code></p><p><code>1169</code><code>          </code></p><p><code>1170</code><code>&lt;div id="section3" class="section toc-section"&gt;&lt;a id="s4c" name="s4c" class="link-target" title="Computation of dormancy scores"&gt;&lt;/a&gt;</code></p><p><code>1171</code><code>&lt;h3&gt;Computation of dormancy scores&lt;/h3&gt;</code></p><p><code>1172</code><code>&lt;a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We defined dormancy score for the i&lt;sup&gt;th&lt;/sup&gt; sample of each data set as following:&lt;a name="" id="" class="link-target"&gt;&lt;/a&gt;&lt;span class="equation"&gt;&lt;img src="article/file?type=thumbnail&amp;amp;id=10.1371/journal.pone.0035569.e001" loading="lazy" class="inline-graphic"&gt;&lt;/span&gt;&lt;/p&gt;</code></p><p><code>1173</code><code>&lt;a id="article1.body1.sec4.sec3.p2" name="article1.body1.sec4.sec3.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;where x&lt;sub&gt;i1&lt;/sub&gt;, …, x&lt;sub&gt;i22&lt;/sub&gt; are intensities of the 22 up-regulated genes, &lt;span class="inline-formula"&gt;&lt;img src="article/file?type=thumbnail&amp;amp;id=10.1371/journal.pone.0035569.e002" loading="lazy" class="inline-graphic"&gt;&lt;/span&gt; is the average intensity of j&lt;sup&gt;th&lt;/sup&gt; up-regulated gene across all samples, y&lt;sub&gt;i1&lt;/sub&gt;, …, y&lt;sub&gt;i27&lt;/sub&gt; are intensities of the 27 down-regulated genes, and &lt;span class="inline-formula"&gt;&lt;img src="article/file?type=thumbnail&amp;amp;id=10.1371/journal.pone.0035569.e003" loading="lazy" class="inline-graphic"&gt;&lt;/span&gt; is the average intensity of j&lt;sup&gt;th&lt;/sup&gt; down-regulated gene across all samples (&lt;a href="#pone-0035569-t001"&gt;Table 1&lt;/a&gt;). In van de Vijver et al., the arguments for the logarithmic functions are directly measured for each gene: the ratio between the intensity of a sample and the average intensity across all samples is measured by the relative brightness of cy-labeled cRNA and reverse-color cy-labeled pool (See Preprocessing of microarray data). For all other data sets, we computed the ratios by averaging the intensities across samples. There were no probes for BHLHE41 or HIST1H2BK in the van de Vijver data set and thus the calculation of the dormancy score for that data set did not include those genes, all other data sets included probes for all the dormancy signature genes.&lt;/p&gt;</code></p><p><code>1174</code><code>&lt;/div&gt;</code></p><p><code>1175</code><code>          </code></p><p><code>1176</code><code>&lt;div id="section4" class="section toc-section"&gt;&lt;a id="s4d" name="s4d" class="link-target" title="Statistical Analyses"&gt;&lt;/a&gt;</code></p><p><code>1177</code><code>&lt;h3&gt;Statistical Analyses&lt;/h3&gt;</code></p><p><code>1178</code><code>&lt;a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We performed the Mann-Whitney test &lt;a href="#pone.0035569-Hollander1" class="ref-tip"&gt;[21]&lt;/a&gt; to compare dormancy scores of ER+ versus ER- cell lines or tumors in each study For analyses pooling samples from all four clinical studies, we performed the stratified Mann-Whitney test (or van Elteren's test, &lt;a href="#pone.0035569-Adorno1" class="ref-tip"&gt;[19]&lt;/a&gt;),stratifying by study.&lt;/p&gt;</code></p><p><code>1179</code><code>&lt;a id="article1.body1.sec4.sec4.p2" name="article1.body1.sec4.sec4.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;In addition, for each clinical study, we tested the association between dormancy and the hazard of distant metastasis by first separating tumors by dormancy score into three equally sized groups: tumors with High/Mid/Low Dormancy scores, referred to as HDS, MDS, or LDS, respectively. Then we tested if the hazards of metastasis were different for the HDS group and LDS groups by fitting a Cox proportional hazards model &lt;a href="#pone.0035569-Andersen1" class="ref-tip"&gt;[22]&lt;/a&gt; using samples in all three groups. Kaplan-Meier estimates of relapse-free survival were computed and plotted for 6 groups: ER+ patients with high dormancy scores (HDS), ER + patients with MDS, ER+ patients with LDS, ER- patients with HDS, ER- patients with MDS, and ER- patients with LDS. For analysis pooling all samples from four clinical studies, we performed Cox's proportional hazards regression analysis stratified by studies.&lt;/p&gt;</code></p><p><code>1180</code><code>&lt;a id="article1.body1.sec4.sec4.p3" name="article1.body1.sec4.sec4.p3" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;We used time-to-distant metastasis in Loi et al. and van de Vijver et al. as the outcome. In Wang et al. and Pawitan et al., we used time-to-relapse (local or distant) as outcome because it was the only available recurrence measurement in their studies. All statistical analyses were performed using the R statistical environment &lt;a href="#pone.0035569-Team1" class="ref-tip"&gt;[23]&lt;/a&gt;. The code and data files used for analysis are available as supporting information (&lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt;, &lt;a href="#pone.0035569.s002"&gt;Dataset S1&lt;/a&gt;, &lt;a href="#pone.0035569.s003"&gt;Dataset S2&lt;/a&gt;, &lt;a href="#pone.0035569.s004"&gt;Dataset S3&lt;/a&gt;, &lt;a href="#pone.0035569.s005"&gt;Dataset S4&lt;/a&gt;, &lt;a href="#pone.0035569.s006"&gt;Dataset S5&lt;/a&gt; and &lt;a href="#pone.0035569.s007"&gt;Dataset S6&lt;/a&gt;).&lt;/p&gt;</code></p><p><code>1181</code><code>&lt;/div&gt;</code></p><p><code>1182</code><code>          </code></p><p><code>1183</code><code>&lt;div id="section5" class="section toc-section"&gt;&lt;a id="s4e" name="s4e" class="link-target" title="Xenograft studies"&gt;&lt;/a&gt;</code></p><p><code>1184</code><code>&lt;h3&gt;Xenograft studies&lt;/h3&gt;</code></p><p><code>1185</code><code>&lt;a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;The experiments involving animals were performed according to standards approved by the IACUC of Albert Einstein College of Medicine and Mount Sinai School of Medicine. For comparing MCF7, MDA-MB-231 and T47D lines in vivo, lines were grown in DMEM (Life Technologies) supplemented with 10% FBS (Atlanta Biologicals) and (Gemini Bio-Products), FBS, and 0.5% penicillin/streptomycin (Invitrogen). Cells were labeled with 5 uM CellTrace Violet (Invitrogen) for 20 minutes and then cultured overnight. The next day, cells were trypsinized, centrifuged to remove trypsin, resuspended in PBS and diluted 1∶1 with Matrigel to a final concentration of 5 million/ml. 0.1 ml was injected into the mammary fat pad of 6–8 week old female SCID mice. For T47D and MCF7 injections, an estrogen pellet (0.36 mg, 60 day release, Innovative Research of America) was inserted subcutaneously the day before injection of tumor cells. Cell Trace labeling was quantitated using FACS analysis using Rainbow standards. After 3 days, the animals were euthanized, the mammary fat pad was dissected out, chopped into fine pieces, and dissociated in PBS with collagenase IV (final concentration of 6 mg/ml, C5138, Sigma), hyaluronidase (final concentration of 1 mg/ml, H3506, Sigma), and DNase I (final concentration of 0.25 mg/ml, D5025-15KU, Sigma) for 30 minutes with continuous agitation at 37 degrees Celsius. Following digestion, samples were washed twice in sterile PBS, filtered for single cells, and analyzed by flow cytometry for level of Cell Trace labeling of tumor cells and number of tumor cells using the GFP labeling to identify tumor cells.&lt;/p&gt;</code></p><p><code>1186</code><code>&lt;a id="article1.body1.sec4.sec5.p2" name="article1.body1.sec4.sec5.p2" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;For siRNA experiments, MCF-7 cells were cultured on DMEM medium (Cellgro) supplemented with 10% FBS (HyClone) and 1% Penicillin/Streptomycin (Gibco). After reaching 80% confluence, cultures were transfected with siRNAs targeting BHLHE41 (Santa Cruz), NR2F1 (Ambion) or control scrambled siRNA (Ambion) at a final concentration of 80 nM using Lipofectamine™ RNAiMAX (Invitrogen) and following the manufacturer instructions. A second transfection was performed after 24 hours to achieve an efficient knockdown. siRNA knockdown was analyzed by qPCR using iQ SYBR® Green Supermix (BioRad). 48 h post-transfection cells were washed, detached and resuspended on PBS+/+ at a concentration of 4×10&lt;sup&gt;6&lt;/sup&gt; cells/70 µL PBS+/+. Prior to injection, 70 µL of Matrigel (Becton Dickinson) was added to the mix and a total of 140 µL was injected into the left mammary fat pad of female NSG mice (n = 15). Tumors were monitored 3 days after injection and thereafter for tumor take. Palpable tumors were measured and size was calculated following the equation [(length×width&lt;sup&gt;2&lt;/sup&gt;)/2] = tumor volume (mm&lt;sup&gt;3&lt;/sup&gt;).&lt;/p&gt;</code></p><p><code>1187</code><code>&lt;/div&gt;</code></p><p><code>1188</code><code>          </code></p><p><code>1189</code><code>&lt;div id="section6" class="section toc-section"&gt;&lt;a id="s4f" name="s4f" class="link-target" title="Quantitative PCR analysis"&gt;&lt;/a&gt;</code></p><p><code>1190</code><code>&lt;h3&gt;Quantitative PCR analysis&lt;/h3&gt;</code></p><p><code>1191</code><code>&lt;a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;RNA was isolated from MCF-7 cells with TRIzol® reagent following the manufacturer's indications (Invitrogen). Reverse transcription was performed using M-MuLV Reverse Transcriptase (New England Biolabs) and quantitative PCR was performed on a CFX 96™ Real Time System (BIORAD) using iQ SYBR® Green Supermix (Invitrogen) using normalization to GAPDH. The human forward and reverse primer sequences used were: BHLHE41, &lt;span class="gene"&gt;5′- CTGATGCTGTTGCTCGGTTA -3′&lt;/span&gt; and &lt;span class="gene"&gt;5′- TGCAGACTCTGGGACATCTG -3′&lt;/span&gt;, NR2F1, &lt;span class="gene"&gt;5′- GCCTCAAAGCCATCGTGCTG -3′&lt;/span&gt; and &lt;span class="gene"&gt;5′- CCTCACGTACTCCTCCAGTG -3′&lt;/span&gt;, GAPDH &lt;span class="gene"&gt;5′-CCCCTGGCCAAGGTCATCCA-3′&lt;/span&gt; and &lt;span class="gene"&gt;5′- ACAGCCTTGGCAGCGCCAGT-3′&lt;/span&gt;. Statistical analysis was performed with GraphPad Prism 5.0 (San Diego, CA) and &lt;em&gt;p&lt;/em&gt; values were calculated using one-way ANOVA followed by the Bonferroni multiple comparison post test or the unpaired &lt;em&gt;t&lt;/em&gt; test.&lt;/p&gt;</code></p><p><code>1192</code><code>&lt;/div&gt;</code></p><p><code>1193</code><code>&lt;/div&gt;</code></p><p><code>1194</code><code>          </code></p><p><code>1195</code><code>&lt;div xmlns:plos="http://plos.org" id="section5" class="section toc-section"&gt;&lt;a id="s5" name="s5" data-toc="s5" class="link-target" title="Supporting Information"&gt;&lt;/a&gt;&lt;h2&gt;Supporting Information&lt;/h2&gt;&lt;div class="figshare_widget" doi="10.1371/journal.pone.0035569"&gt;&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s001" id="pone.0035569.s001" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s001"&gt;Text S1. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;R code that describes the analyses performed with the supporting information data files.&lt;/p&gt;</code></p><p><code>1196</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s001"&gt;https://doi.org/10.1371/journal.pone.0035569.s001&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(PDF)&lt;/p&gt;</code></p><p><code>1197</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s002" id="pone.0035569.s002" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s002"&gt;Data S1. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as dt.Loi.signature.xls.&lt;/p&gt;</code></p><p><code>1198</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s002"&gt;https://doi.org/10.1371/journal.pone.0035569.s002&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1199</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s003" id="pone.0035569.s003" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s003"&gt;Data S2. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material3.caption1.p1" name="article1.body1.sec5.supplementary-material3.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as dt.Neve.signature.xls.&lt;/p&gt;</code></p><p><code>1200</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s003"&gt;https://doi.org/10.1371/journal.pone.0035569.s003&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material3.caption1.p2" name="article1.body1.sec5.supplementary-material3.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1201</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s004" id="pone.0035569.s004" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s004"&gt;Data S3. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material4.caption1.p1" name="article1.body1.sec5.supplementary-material4.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as dt.NKI295.signature.xls.&lt;/p&gt;</code></p><p><code>1202</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s004"&gt;https://doi.org/10.1371/journal.pone.0035569.s004&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material4.caption1.p2" name="article1.body1.sec5.supplementary-material4.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1203</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s005" id="pone.0035569.s005" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s005"&gt;Data S4. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material5.caption1.p1" name="article1.body1.sec5.supplementary-material5.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as dt.Pawitan.signature.xls.&lt;/p&gt;</code></p><p><code>1204</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s005"&gt;https://doi.org/10.1371/journal.pone.0035569.s005&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material5.caption1.p2" name="article1.body1.sec5.supplementary-material5.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1205</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s006" id="pone.0035569.s006" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s006"&gt;Data S5. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material6.caption1.p1" name="article1.body1.sec5.supplementary-material6.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as dt.Wang.signature.xls.&lt;/p&gt;</code></p><p><code>1206</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s006"&gt;https://doi.org/10.1371/journal.pone.0035569.s006&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material6.caption1.p2" name="article1.body1.sec5.supplementary-material6.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1207</code><code>&lt;/div&gt;&lt;div class="supplementary-material"&gt;&lt;a name="pone.0035569.s007" id="pone.0035569.s007" class="link-target"&gt;&lt;/a&gt;&lt;h3 class="siTitle title-small"&gt;&lt;a href="article/file?type=supplementary&amp;amp;id=10.1371/journal.pone.0035569.s007"&gt;Data S6. &lt;/a&gt;&lt;/h3&gt;&lt;a id="article1.body1.sec5.supplementary-material7.caption1.p1" name="article1.body1.sec5.supplementary-material7.caption1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p class="preSiDOI"&gt;Data set referred to in &lt;a href="#pone.0035569.s001"&gt;Text S1&lt;/a&gt; as si.xls.&lt;/p&gt;</code></p><p><code>1208</code><code>&lt;p class="siDoi"&gt;&lt;a href="https://doi.org/10.1371/journal.pone.0035569.s007"&gt;https://doi.org/10.1371/journal.pone.0035569.s007&lt;/a&gt;&lt;/p&gt;&lt;a id="article1.body1.sec5.supplementary-material7.caption1.p2" name="article1.body1.sec5.supplementary-material7.caption1.p2" class="link-target"&gt;&lt;/a&gt;&lt;p class="postSiDOI"&gt;(XLS)&lt;/p&gt;</code></p><p><code>1209</code><code>&lt;/div&gt;&lt;/div&gt;</code></p><p><code>1210</code><code>          </code></p><p><code>1211</code><code>          </code></p><p><code>1212</code><code>          </code></p><p><code>1213</code><code>          </code></p><p><code>1214</code><code>          </code></p><p><code>1215</code><code>&lt;div xmlns:plos="http://plos.org" class="section toc-section"&gt;&lt;a id="ack" name="ack" data-toc="ack" title="Acknowledgments" class="link-target"&gt;&lt;/a&gt;&lt;h2&gt;Acknowledgments&lt;/h2&gt;</code></p><p><code>1216</code><code>&lt;a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1" class="link-target"&gt;&lt;/a&gt;&lt;p&gt;JES is the Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research.&lt;/p&gt;</code></p><p><code>1217</code><code>&lt;/div&gt;&lt;div xmlns:plos="http://plos.org" class="contributions toc-section"&gt;&lt;a id="authcontrib" name="authcontrib" data-toc="authcontrib" title="Author Contributions"&gt;&lt;/a&gt;&lt;h2&gt;Author Contributions&lt;/h2&gt;&lt;p&gt;Conceived and designed the experiments: RSK JAAG JES. Performed the experiments: AAV YE PB MSSS JES. Analyzed the data: RSK JAAG JES. Contributed reagents/materials/analysis tools: RSK AAV YE PB MSS JAAG JES. Wrote the paper: RSK JAAG JES.&lt;/p&gt;&lt;/div&gt;&lt;div xmlns:plos="http://plos.org" class="toc-section"&gt;&lt;a id="references" name="references" class="link-target" data-toc="references" title="References"&gt;&lt;/a&gt;&lt;h2&gt;References&lt;/h2&gt;&lt;ol class="references"&gt;&lt;li id="ref1"&gt;&lt;span class="order"&gt;1.</code></p><p><code>1218</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Naumov1" id="pone.0035569-Naumov1" class="link-target"&gt;&lt;/a&gt;Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, et al.  (2003) Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat  82: 199–206.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Naumov" data-cit="NaumovGNTownsonJLMacDonaldICWilsonSMBramwellVH2003Ineffectiveness%20of%20doxorubicin%20treatment%20on%20solitary%20dormant%20mammary%20carcinoma%20cells%20or%20late-developing%20metastases.Breast%20Cancer%20Res%20Treat82199206" data-title="Ineffectiveness%20of%20doxorubicin%20treatment%20on%20solitary%20dormant%20mammary%20carcinoma%20cells%20or%20late-developing%20metastases." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1219</code><code>                      View Article</code></p><p><code>1220</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Ineffectiveness+of+doxorubicin+treatment+on+solitary+dormant+mammary+carcinoma+cells+or+late-developing+metastases.+Naumov+2003" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1221</code><code>                      Google Scholar</code></p><p><code>1222</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref2"&gt;&lt;span class="order"&gt;2.</code></p><p><code>1223</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Muller1" id="pone.0035569-Muller1" class="link-target"&gt;&lt;/a&gt;Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, et al.  (2005) Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res  11: 3678–3685.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Muller" data-cit="MullerVStahmannNRiethdorfSRauTZabelT2005Circulating%20tumor%20cells%20in%20breast%20cancer%3A%20correlation%20to%20bone%20marrow%20micrometastases%2C%20heterogeneous%20response%20to%20systemic%20therapy%20and%20low%20proliferative%20activity.Clin%20Cancer%20Res1136783685" data-title="Circulating%20tumor%20cells%20in%20breast%20cancer%3A%20correlation%20to%20bone%20marrow%20micrometastases%2C%20heterogeneous%20response%20to%20systemic%20therapy%20and%20low%20proliferative%20activity." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1224</code><code>                      View Article</code></p><p><code>1225</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Circulating+tumor+cells+in+breast+cancer%3A+correlation+to+bone+marrow+micrometastases%2C+heterogeneous+response+to+systemic+therapy+and+low+proliferative+activity.+Muller+2005" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1226</code><code>                      Google Scholar</code></p><p><code>1227</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref3"&gt;&lt;span class="order"&gt;3.</code></p><p><code>1228</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Pantel1" id="pone.0035569-Pantel1" class="link-target"&gt;&lt;/a&gt;Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer  4: 448–456.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Pantel" data-cit="PantelKBrakenhoffRH2004Dissecting%20the%20metastatic%20cascade.Nat%20Rev%20Cancer4448456" data-title="Dissecting%20the%20metastatic%20cascade." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1229</code><code>                      View Article</code></p><p><code>1230</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Dissecting+the+metastatic+cascade.+Pantel+2004" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1231</code><code>                      Google Scholar</code></p><p><code>1232</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref4"&gt;&lt;span class="order"&gt;4.</code></p><p><code>1233</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-AguirreGhiso1" id="pone.0035569-AguirreGhiso1" class="link-target"&gt;&lt;/a&gt;Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer  7: 834–846.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Aguirre-Ghiso" data-cit="Aguirre-GhisoJA2007Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy.Nat%20Rev%20Cancer7834846" data-title="Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1234</code><code>                      View Article</code></p><p><code>1235</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Models%2C+mechanisms+and+clinical+evidence+for+cancer+dormancy.+Aguirre-Ghiso+2007" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1236</code><code>                      Google Scholar</code></p><p><code>1237</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref5"&gt;&lt;span class="order"&gt;5.</code></p><p><code>1238</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Vessella1" id="pone.0035569-Vessella1" class="link-target"&gt;&lt;/a&gt;Vessella RL, Pantel K, Mohla S (2007) Tumor Cell Dormancy: An NCI Workshop Report. Cancer Biol Ther  6:   &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Vessella" data-cit="VessellaRLPantelKMohlaS2007Tumor%20Cell%20Dormancy%3A%20An%20NCI%20Workshop%20Report.Cancer%20Biol%20Ther6" data-title="Tumor%20Cell%20Dormancy%3A%20An%20NCI%20Workshop%20Report." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1239</code><code>                      View Article</code></p><p><code>1240</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Tumor+Cell+Dormancy%3A+An+NCI+Workshop+Report.+Vessella+2007" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1241</code><code>                      Google Scholar</code></p><p><code>1242</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref6"&gt;&lt;span class="order"&gt;6.</code></p><p><code>1243</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Adam1" id="pone.0035569-Adam1" class="link-target"&gt;&lt;/a&gt;Adam AP, George A, Schewe D, Bragado P, Iglesias BV, et al.  (2009) Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res  69: 5664–5672.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Adam" data-cit="AdamAPGeorgeAScheweDBragadoPIglesiasBV2009Computational%20identification%20of%20a%20p38SAPK-regulated%20transcription%20factor%20network%20required%20for%20tumor%20cell%20quiescence.Cancer%20Res6956645672" data-title="Computational%20identification%20of%20a%20p38SAPK-regulated%20transcription%20factor%20network%20required%20for%20tumor%20cell%20quiescence." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1244</code><code>                      View Article</code></p><p><code>1245</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Computational+identification+of+a+p38SAPK-regulated+transcription+factor+network+required+for+tumor+cell+quiescence.+Adam+2009" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1246</code><code>                      Google Scholar</code></p><p><code>1247</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref7"&gt;&lt;span class="order"&gt;7.</code></p><p><code>1248</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Almog1" id="pone.0035569-Almog1" class="link-target"&gt;&lt;/a&gt;Almog N, Ma L, Raychowdhury R, Schwager C, Erber R, et al.  (2009) Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res  69: 836–844.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Almog" data-cit="AlmogNMaLRaychowdhuryRSchwagerCErberR2009Transcriptional%20switch%20of%20dormant%20tumors%20to%20fast-growing%20angiogenic%20phenotype.Cancer%20Res69836844" data-title="Transcriptional%20switch%20of%20dormant%20tumors%20to%20fast-growing%20angiogenic%20phenotype." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1249</code><code>                      View Article</code></p><p><code>1250</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Transcriptional+switch+of+dormant+tumors+to+fast-growing+angiogenic+phenotype.+Almog+2009" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1251</code><code>                      Google Scholar</code></p><p><code>1252</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref8"&gt;&lt;span class="order"&gt;8.</code></p><p><code>1253</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Neve1" id="pone.0035569-Neve1" class="link-target"&gt;&lt;/a&gt;Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al.  (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell  10: 515–527.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Neve" data-cit="NeveRMChinKFridlyandJYehJBaehnerFL2006A%20collection%20of%20breast%20cancer%20cell%20lines%20for%20the%20study%20of%20functionally%20distinct%20cancer%20subtypes.Cancer%20Cell10515527" data-title="A%20collection%20of%20breast%20cancer%20cell%20lines%20for%20the%20study%20of%20functionally%20distinct%20cancer%20subtypes." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1254</code><code>                      View Article</code></p><p><code>1255</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=A+collection+of+breast+cancer+cell+lines+for+the+study+of+functionally+distinct+cancer+subtypes.+Neve+2006" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1256</code><code>                      Google Scholar</code></p><p><code>1257</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref9"&gt;&lt;span class="order"&gt;9.</code></p><p><code>1258</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Kenny1" id="pone.0035569-Kenny1" class="link-target"&gt;&lt;/a&gt;Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, et al.  (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol  1: 84–96.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Kenny" data-cit="KennyPALeeGYMyersCANeveRMSemeiksJR2007The%20morphologies%20of%20breast%20cancer%20cell%20lines%20in%20three-dimensional%20assays%20correlate%20with%20their%20profiles%20of%20gene%20expression.Mol%20Oncol18496" data-title="The%20morphologies%20of%20breast%20cancer%20cell%20lines%20in%20three-dimensional%20assays%20correlate%20with%20their%20profiles%20of%20gene%20expression." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1259</code><code>                      View Article</code></p><p><code>1260</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=The+morphologies+of+breast+cancer+cell+lines+in+three-dimensional+assays+correlate+with+their+profiles+of+gene+expression.+Kenny+2007" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1261</code><code>                      Google Scholar</code></p><p><code>1262</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref10"&gt;&lt;span class="order"&gt;10.</code></p><p><code>1263</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Loi1" id="pone.0035569-Loi1" class="link-target"&gt;&lt;/a&gt;Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, et al.  (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol  25: 1239–1246.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Loi" data-cit="LoiSHaibe-KainsBDesmedtCLallemandFTuttAM2007Definition%20of%20clinically%20distinct%20molecular%20subtypes%20in%20estrogen%20receptor-positive%20breast%20carcinomas%20through%20genomic%20grade.J%20Clin%20Oncol2512391246" data-title="Definition%20of%20clinically%20distinct%20molecular%20subtypes%20in%20estrogen%20receptor-positive%20breast%20carcinomas%20through%20genomic%20grade." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1264</code><code>                      View Article</code></p><p><code>1265</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Definition+of+clinically+distinct+molecular+subtypes+in+estrogen+receptor-positive+breast+carcinomas+through+genomic+grade.+Loi+2007" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1266</code><code>                      Google Scholar</code></p><p><code>1267</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref11"&gt;&lt;span class="order"&gt;11.</code></p><p><code>1268</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Wang1" id="pone.0035569-Wang1" class="link-target"&gt;&lt;/a&gt;Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al.  (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet  365: 671–679.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Wang" data-cit="WangYKlijnJGZhangYSieuwertsAMLookMP2005Gene-expression%20profiles%20to%20predict%20distant%20metastasis%20of%20lymph-node-negative%20primary%20breast%20cancer.Lancet365671679" data-title="Gene-expression%20profiles%20to%20predict%20distant%20metastasis%20of%20lymph-node-negative%20primary%20breast%20cancer." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1269</code><code>                      View Article</code></p><p><code>1270</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Gene-expression+profiles+to+predict+distant+metastasis+of+lymph-node-negative+primary+breast+cancer.+Wang+2005" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1271</code><code>                      Google Scholar</code></p><p><code>1272</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref12"&gt;&lt;span class="order"&gt;12.</code></p><p><code>1273</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Pawitan1" id="pone.0035569-Pawitan1" class="link-target"&gt;&lt;/a&gt;Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al.  (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res  7: R953–964.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Pawitan" data-cit="PawitanYBjohleJAmlerLBorgALEgyhaziS2005Gene%20expression%20profiling%20spares%20early%20breast%20cancer%20patients%20from%20adjuvant%20therapy%3A%20derived%20and%20validated%20in%20two%20population-based%20cohorts.Breast%20Cancer%20Res7R953964" data-title="Gene%20expression%20profiling%20spares%20early%20breast%20cancer%20patients%20from%20adjuvant%20therapy%3A%20derived%20and%20validated%20in%20two%20population-based%20cohorts." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1274</code><code>                      View Article</code></p><p><code>1275</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Gene+expression+profiling+spares+early+breast+cancer+patients+from+adjuvant+therapy%3A+derived+and+validated+in+two+population-based+cohorts.+Pawitan+2005" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1276</code><code>                      Google Scholar</code></p><p><code>1277</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref13"&gt;&lt;span class="order"&gt;13.</code></p><p><code>1278</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-vandeVijver1" id="pone.0035569-vandeVijver1" class="link-target"&gt;&lt;/a&gt;van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al.  (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med  347: 1999–2009.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="van%20de%20Vijver" data-cit="van%20de%20VijverMJHeYDvan%27t%20VeerLJDaiHHartAA2002A%20gene-expression%20signature%20as%20a%20predictor%20of%20survival%20in%20breast%20cancer.N%20Engl%20J%20Med34719992009" data-title="A%20gene-expression%20signature%20as%20a%20predictor%20of%20survival%20in%20breast%20cancer." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1279</code><code>                      View Article</code></p><p><code>1280</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=A+gene-expression+signature+as+a+predictor+of+survival+in+breast+cancer.+van+de+Vijver+2002" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1281</code><code>                      Google Scholar</code></p><p><code>1282</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref14"&gt;&lt;span class="order"&gt;14.</code></p><p><code>1283</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Klopp1" id="pone.0035569-Klopp1" class="link-target"&gt;&lt;/a&gt;Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, et al.  (2010) Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One  5: e12180.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Klopp" data-cit="KloppAHLacerdaLGuptaADebebBGSolleyT2010Mesenchymal%20stem%20cells%20promote%20mammosphere%20formation%20and%20decrease%20E-cadherin%20in%20normal%20and%20malignant%20breast%20cells.PLoS%20One5e12180" data-title="Mesenchymal%20stem%20cells%20promote%20mammosphere%20formation%20and%20decrease%20E-cadherin%20in%20normal%20and%20malignant%20breast%20cells." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1284</code><code>                      View Article</code></p><p><code>1285</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Mesenchymal+stem+cells+promote+mammosphere+formation+and+decrease+E-cadherin+in+normal+and+malignant+breast+cells.+Klopp+2010" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1286</code><code>                      Google Scholar</code></p><p><code>1287</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref15"&gt;&lt;span class="order"&gt;15.</code></p><p><code>1288</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Early1" id="pone.0035569-Early1" class="link-target"&gt;&lt;/a&gt;Early Breast Cancer Trialists' Collaborative Group E (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet  365: 1687–1717.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="" data-cit="Early%20Breast%20Cancer%20Trialists%27%20Collaborative%20Group%20E2005Effects%20of%20chemotherapy%20and%20hormonal%20therapy%20for%20early%20breast%20cancer%20on%20recurrence%20and%2015-year%20survival%3A%20an%20overview%20of%20the%20randomised%20trials.Lancet36516871717" data-title="Effects%20of%20chemotherapy%20and%20hormonal%20therapy%20for%20early%20breast%20cancer%20on%20recurrence%20and%2015-year%20survival%3A%20an%20overview%20of%20the%20randomised%20trials." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1289</code><code>                      View Article</code></p><p><code>1290</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Effects+of+chemotherapy+and+hormonal+therapy+for+early+breast+cancer+on+recurrence+and+15-year+survival%3A+an+overview+of+the+randomised+trials.++2005" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1291</code><code>                      Google Scholar</code></p><p><code>1292</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref16"&gt;&lt;span class="order"&gt;16.</code></p><p><code>1293</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Tran1" id="pone.0035569-Tran1" class="link-target"&gt;&lt;/a&gt;Tran B, Bedard PL (2011) Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res  13: 221.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Tran" data-cit="TranBBedardPL2011Luminal-B%20breast%20cancer%20and%20novel%20therapeutic%20targets.Breast%20Cancer%20Res13221" data-title="Luminal-B%20breast%20cancer%20and%20novel%20therapeutic%20targets." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1294</code><code>                      View Article</code></p><p><code>1295</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Luminal-B+breast+cancer+and+novel+therapeutic+targets.+Tran+2011" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1296</code><code>                      Google Scholar</code></p><p><code>1297</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref17"&gt;&lt;span class="order"&gt;17.</code></p><p><code>1298</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Takekawa1" id="pone.0035569-Takekawa1" class="link-target"&gt;&lt;/a&gt;Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, et al.  (2002) Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta. Embo J  21: 6473–6482.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Takekawa" data-cit="TakekawaMTatebayashiKItohFAdachiMImaiK2002Smad-dependent%20GADD45beta%20expression%20mediates%20delayed%20activation%20of%20p38%20MAP%20kinase%20by%20TGF-beta.Embo%20J2164736482" data-title="Smad-dependent%20GADD45beta%20expression%20mediates%20delayed%20activation%20of%20p38%20MAP%20kinase%20by%20TGF-beta." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1299</code><code>                      View Article</code></p><p><code>1300</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Smad-dependent+GADD45beta+expression+mediates+delayed+activation+of+p38+MAP+kinase+by+TGF-beta.+Takekawa+2002" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1301</code><code>                      Google Scholar</code></p><p><code>1302</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref18"&gt;&lt;span class="order"&gt;18.</code></p><p><code>1303</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-McGillicuddy1" id="pone.0035569-McGillicuddy1" class="link-target"&gt;&lt;/a&gt;McGillicuddy FC, O'Toole D, Hickey JA, Gallagher WM, Dawson KA, et al.  (2006) TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol  44: 469–475.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="McGillicuddy" data-cit="McGillicuddyFCO%27TooleDHickeyJAGallagherWMDawsonKA2006TGF-beta1-induced%20thrombospondin-1%20expression%20through%20the%20p38%20MAPK%20pathway%20is%20abolished%20by%20fluvastatin%20in%20human%20coronary%20artery%20smooth%20muscle%20cells.Vascul%20Pharmacol44469475" data-title="TGF-beta1-induced%20thrombospondin-1%20expression%20through%20the%20p38%20MAPK%20pathway%20is%20abolished%20by%20fluvastatin%20in%20human%20coronary%20artery%20smooth%20muscle%20cells." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1304</code><code>                      View Article</code></p><p><code>1305</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=TGF-beta1-induced+thrombospondin-1+expression+through+the+p38+MAPK+pathway+is+abolished+by+fluvastatin+in+human+coronary+artery+smooth+muscle+cells.+McGillicuddy+2006" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1306</code><code>                      Google Scholar</code></p><p><code>1307</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref19"&gt;&lt;span class="order"&gt;19.</code></p><p><code>1308</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Adorno1" id="pone.0035569-Adorno1" class="link-target"&gt;&lt;/a&gt;Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, et al.  (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell  137: 87–98.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Adorno" data-cit="AdornoMCordenonsiMMontagnerMDupontSWongC2009A%20Mutant-p53%2FSmad%20complex%20opposes%20p63%20to%20empower%20TGFbeta-induced%20metastasis.Cell1378798" data-title="A%20Mutant-p53%2FSmad%20complex%20opposes%20p63%20to%20empower%20TGFbeta-induced%20metastasis." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1309</code><code>                      View Article</code></p><p><code>1310</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=A+Mutant-p53%2FSmad+complex+opposes+p63+to+empower+TGFbeta-induced+metastasis.+Adorno+2009" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1311</code><code>                      Google Scholar</code></p><p><code>1312</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref20"&gt;&lt;span class="order"&gt;20.</code></p><p><code>1313</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Li1" id="pone.0035569-Li1" class="link-target"&gt;&lt;/a&gt;Li C, Wong WH (2003)  DNA-Chip Analyzer (dChip). In:  Parmigiani G, Garrett ES, Irizarry R, Zeger SL, editors. The analysis of gene expression data: methods and software. New York: Springer. pp. 120–141.  &lt;ul class="find-nolinks"&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref21"&gt;&lt;span class="order"&gt;21.</code></p><p><code>1314</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Hollander1" id="pone.0035569-Hollander1" class="link-target"&gt;&lt;/a&gt;Hollander MW, Douglas A (1973) Nonparametric Statistical Methods. New York: John Wiley &amp;amp; Sons.   &lt;ul class="find-nolinks"&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref22"&gt;&lt;span class="order"&gt;22.</code></p><p><code>1315</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Andersen1" id="pone.0035569-Andersen1" class="link-target"&gt;&lt;/a&gt;Andersen PG, Gill RD (1982) Cox's regression model for counting processes, a large sample study. Annals of Statistics  10: 1100–1120.  &lt;ul class="reflinks"&gt;&lt;li&gt;&lt;a href="#" data-author="Andersen" data-cit="AndersenPGGillRD1982Cox%27s%20regression%20model%20for%20counting%20processes%2C%20a%20large%20sample%20study.Annals%20of%20Statistics1011001120" data-title="Cox%26apos%3Bs%20regression%20model%20for%20counting%20processes%2C%20a%20large%20sample%20study." target="_new" title="Go to article in CrossRef"&gt;</code></p><p><code>1316</code><code>                      View Article</code></p><p><code>1317</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://scholar.google.com/scholar?q=Cox%26apos%3Bs+regression+model+for+counting+processes%2C+a+large+sample+study.+Andersen+1982" target="_new" title="Go to article in Google Scholar"&gt;</code></p><p><code>1318</code><code>                      Google Scholar</code></p><p><code>1319</code><code>                    &lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li id="ref23"&gt;&lt;span class="order"&gt;23.</code></p><p><code>1320</code><code>            &lt;/span&gt;&lt;a name="pone.0035569-Team1" id="pone.0035569-Team1" class="link-target"&gt;&lt;/a&gt;Team RDC (2009) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.   &lt;ul class="find-nolinks"&gt;&lt;/ul&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;</code></p><p><code>1321</code><code>          </code></p><p><code>1322</code><code>          </code></p><p><code>1323</code><code>          </code></p><p><code>1324</code><code>          &lt;div class="ref-tooltip"&gt;</code></p><p><code>1325</code><code>            &lt;div class="ref_tooltip-content"&gt;</code></p><p><code>1326</code><code>          </code></p><p><code>1327</code><code>            &lt;/div&gt;</code></p><p><code>1328</code><code>          &lt;/div&gt;</code></p><p><code>1329</code><code>          </code></p><p><code>1330</code><code>        &lt;/div&gt;</code></p><p><code>1331</code><code>      &lt;/div&gt;</code></p><p><code>1332</code><code>    &lt;/div&gt;</code></p><p><code>1333</code><code>          </code></p><p><code>1334</code><code>  &lt;/section&gt;</code></p><p><code>1335</code><code>  &lt;aside class="article-aside"&gt;</code></p><p><code>1336</code><code>          </code></p><p><code>1337</code><code>          </code></p><p><code>1338</code><code>&lt;!--[if IE 9]&gt;</code></p><p><code>1339</code><code>&lt;style&gt;</code></p><p><code>1340</code><code>.dload-xml {margin-top: 38px}</code></p><p><code>1341</code><code>&lt;/style&gt;</code></p><p><code>1342</code><code>&lt;![endif]--&gt;</code></p><p><code>1343</code><code>&lt;div class="dload-menu"&gt;</code></p><p><code>1344</code><code>  &lt;div class="dload-pdf"&gt;</code></p><p><code>1345</code><code>    &lt;a href="/plosone/article/file?id=10.1371/journal.pone.0035569&amp;type=printable"</code></p><p><code>1346</code><code>       id="downloadPdf" target="_blank"&gt;Download PDF&lt;/a&gt;</code></p><p><code>1347</code><code>  &lt;/div&gt;</code></p><p><code>1348</code><code>  &lt;div data-js-tooltip-hover="trigger" class="dload-hover"&gt;&amp;nbsp;</code></p><p><code>1349</code><code>    &lt;ul class="dload-xml" data-js-tooltip-hover="target"&gt;</code></p><p><code>1350</code><code>      &lt;li&gt;&lt;a href="/plosone/article/citation?id=10.1371/journal.pone.0035569"</code></p><p><code>1351</code><code>             id="downloadCitation"&gt;Citation&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1352</code><code>      &lt;li&gt;&lt;a href="/plosone/article/file?id=10.1371/journal.pone.0035569&amp;type=manuscript"</code></p><p><code>1353</code><code>             id="downloadXml"&gt;XML&lt;/a&gt;</code></p><p><code>1354</code><code>      &lt;/li&gt;</code></p><p><code>1355</code><code>    &lt;/ul&gt;</code></p><p><code>1356</code><code>          </code></p><p><code>1357</code><code>  &lt;/div&gt;</code></p><p><code>1358</code><code>&lt;/div&gt;</code></p><p><code>1359</code><code>          </code></p><p><code>1360</code><code>&lt;div class="aside-container"&gt;</code></p><p><code>1361</code><code>  &lt;div class="print-article" id="printArticle" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>1362</code><code>    &lt;a href="#" onclick="window.print(); return false;" class="preventDefault" id="printBrowser"&gt;Print&lt;/a&gt;</code></p><p><code>1363</code><code>  &lt;/div&gt;</code></p><p><code>1364</code><code>  &lt;div class="share-article" id="shareArticle" data-js-tooltip-hover="trigger"&gt;</code></p><p><code>1365</code><code>    Share</code></p><p><code>1366</code><code>    &lt;ul data-js-tooltip-hover="target" class="share-options" id="share-options"&gt;</code></p><p><code>1367</code><code>          </code></p><p><code>1368</code><code>      &lt;li&gt;&lt;a href="https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569" id="shareReddit" target="_blank" title="Submit to Reddit"&gt;&lt;img src="/resource/img/icon.reddit.16.png" width="16" height="16" alt="Reddit"&gt;Reddit&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1369</code><code>          </code></p><p><code>1370</code><code>      &lt;li&gt;&lt;a href="https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569&amp;t=Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer" id="shareFacebook" target="_blank" title="Share on Facebook"&gt;&lt;img src="/resource/img/icon.fb.16.png" width="16" height="16" alt="Facebook"&gt;Facebook&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1371</code><code>          </code></p><p><code>1372</code><code>      &lt;li&gt;&lt;a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569&amp;title=Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer&amp;summary=Checkout this article I found at PLOS"  id="shareLinkedIn" target="_blank" title="Add to LinkedIn"&gt;&lt;img src="/resource/img/icon.linkedin.16.png" width="16" height="16" alt="LinkedIn"&gt;LinkedIn&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1373</code><code>          </code></p><p><code>1374</code><code>      &lt;li&gt;&lt;a href="https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569"  id="shareMendeley" target="_blank" title="Add to Mendeley"&gt;&lt;img src="/resource/img/icon.mendeley.16.png" width="16" height="16" alt="Mendeley"&gt;Mendeley&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1375</code><code>          </code></p><p><code>1376</code><code>        &lt;li&gt;&lt;a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569&amp;text=%23PLOSONE%3A%20Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer" target="_blank" title="share on Twitter" id="twitter-share-link"&gt;&lt;img src="/resource/img/icon.twtr.16.png" width="16" height="16" alt="Twitter"&gt;Twitter&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1377</code><code>          </code></p><p><code>1378</code><code>      &lt;li&gt;&lt;a href="mailto:?subject=Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer&amp;body=I%20thought%20you%20would%20find%20this%20article%20interesting.%20From%20PLOS ONE:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0035569"  id="shareEmail" rel="noreferrer" aria-label="Email"&gt;&lt;img src="/resource/img/icon.email.16.png" width="16" height="16" alt="Email"&gt;Email&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1379</code><code>      &lt;script src="/resource/js/components/tweet140.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1380</code><code>    &lt;/ul&gt;</code></p><p><code>1381</code><code>  &lt;/div&gt;</code></p><p><code>1382</code><code>&lt;/div&gt;</code></p><p><code>1383</code><code>          </code></p><p><code>1384</code><code>          </code></p><p><code>1385</code><code>     &lt;!-- Crossmark 2.0 widget --&gt;</code></p><p><code>1386</code><code>    &lt;script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"&gt;&lt;/script&gt;</code></p><p><code>1387</code><code>    &lt;a aria-label="Check for updates via CrossMark" data-target="crossmark"&gt;</code></p><p><code>1388</code><code>      &lt;img alt="Check for updates via CrossMark" width="150" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg"&gt;</code></p><p><code>1389</code><code>    &lt;/a&gt;</code></p><p><code>1390</code><code>    &lt;!-- End Crossmark 2.0 widget --&gt;</code></p><p><code>1391</code><code>          </code></p><p><code>1392</code><code>          </code></p><p><code>1393</code><code>          </code></p><p><code>1394</code><code>&lt;div class="aside-container collections-aside-container"&gt;&lt;!-- React Magic --&gt;&lt;/div&gt;</code></p><p><code>1395</code><code>          </code></p><p><code>1396</code><code>          </code></p><p><code>1397</code><code>&lt;div class="skyscraper-container"&gt;</code></p><p><code>1398</code><code>  &lt;div class="title"&gt;Advertisement&lt;/div&gt;</code></p><p><code>1399</code><code>&lt;!-- DoubleClick Ad Zone --&gt;</code></p><p><code>1400</code><code>  &lt;div class='advertisement' id='div-gpt-ad-1458247671871-1' style='width:160px; height:600px;'&gt;</code></p><p><code>1401</code><code>    &lt;script type='text/javascript'&gt;</code></p><p><code>1402</code><code>      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-1'); });</code></p><p><code>1403</code><code>    &lt;/script&gt;</code></p><p><code>1404</code><code>  &lt;/div&gt;</code></p><p><code>1405</code><code>&lt;/div&gt;</code></p><p><code>1406</code><code>          </code></p><p><code>1407</code><code>          </code></p><p><code>1408</code><code>          </code></p><p><code>1409</code><code>          </code></p><p><code>1410</code><code>&lt;div class="subject-areas-container"&gt;</code></p><p><code>1411</code><code>  &lt;h3&gt;Subject Areas &lt;div id="subjInfo"&gt;?&lt;/div&gt;</code></p><p><code>1412</code><code>    &lt;div id="subjInfoText"&gt;</code></p><p><code>1413</code><code>      &lt;p&gt;For more information about PLOS Subject Areas, click</code></p><p><code>1414</code><code>        &lt;a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window"&gt;here&lt;/a&gt;.&lt;/p&gt;</code></p><p><code>1415</code><code>      &lt;span class="inline-intro"&gt;We want your feedback.&lt;/span&gt; Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!</code></p><p><code>1416</code><code>          </code></p><p><code>1417</code><code>          </code></p><p><code>1418</code><code>    &lt;/div&gt;</code></p><p><code>1419</code><code>  &lt;/h3&gt;</code></p><p><code>1420</code><code>  &lt;ul id="subjectList"&gt;</code></p><p><code>1421</code><code>      &lt;li&gt;</code></p><p><code>1422</code><code>              &lt;a class="taxo-term" title="Search for articles about Breast cancer"</code></p><p><code>1423</code><code>                 href="/plosone/search?filterSubjects=Breast+cancer&amp;filterJournals=PLoSONE&amp;q="&gt;Breast cancer&lt;/a&gt;</code></p><p><code>1424</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1425</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Breast cancer"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Breast cancer"&lt;/strong&gt; applicable to this article?</code></p><p><code>1426</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1427</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1428</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1429</code><code>        &lt;/div&gt;</code></p><p><code>1430</code><code>      &lt;/li&gt;</code></p><p><code>1431</code><code>      &lt;li&gt;</code></p><p><code>1432</code><code>              &lt;a class="taxo-term" title="Search for articles about Cancer treatment"</code></p><p><code>1433</code><code>                 href="/plosone/search?filterSubjects=Cancer+treatment&amp;filterJournals=PLoSONE&amp;q="&gt;Cancer treatment&lt;/a&gt;</code></p><p><code>1434</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1435</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Cancer treatment"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Cancer treatment"&lt;/strong&gt; applicable to this article?</code></p><p><code>1436</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1437</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1438</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1439</code><code>        &lt;/div&gt;</code></p><p><code>1440</code><code>      &lt;/li&gt;</code></p><p><code>1441</code><code>      &lt;li&gt;</code></p><p><code>1442</code><code>              &lt;a class="taxo-term" title="Search for articles about Metastasis"</code></p><p><code>1443</code><code>                 href="/plosone/search?filterSubjects=Metastasis&amp;filterJournals=PLoSONE&amp;q="&gt;Metastasis&lt;/a&gt;</code></p><p><code>1444</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1445</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Metastasis"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Metastasis"&lt;/strong&gt; applicable to this article?</code></p><p><code>1446</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1447</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1448</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1449</code><code>        &lt;/div&gt;</code></p><p><code>1450</code><code>      &lt;/li&gt;</code></p><p><code>1451</code><code>      &lt;li&gt;</code></p><p><code>1452</code><code>              &lt;a class="taxo-term" title="Search for articles about Small interfering RNA"</code></p><p><code>1453</code><code>                 href="/plosone/search?filterSubjects=Small+interfering+RNA&amp;filterJournals=PLoSONE&amp;q="&gt;Small interfering RNA&lt;/a&gt;</code></p><p><code>1454</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1455</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Small interfering RNA"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Small interfering RNA"&lt;/strong&gt; applicable to this article?</code></p><p><code>1456</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1457</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1458</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1459</code><code>        &lt;/div&gt;</code></p><p><code>1460</code><code>      &lt;/li&gt;</code></p><p><code>1461</code><code>      &lt;li&gt;</code></p><p><code>1462</code><code>              &lt;a class="taxo-term" title="Search for articles about Fats"</code></p><p><code>1463</code><code>                 href="/plosone/search?filterSubjects=Fats&amp;filterJournals=PLoSONE&amp;q="&gt;Fats&lt;/a&gt;</code></p><p><code>1464</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1465</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Fats"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Fats"&lt;/strong&gt; applicable to this article?</code></p><p><code>1466</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1467</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1468</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1469</code><code>        &lt;/div&gt;</code></p><p><code>1470</code><code>      &lt;/li&gt;</code></p><p><code>1471</code><code>      &lt;li&gt;</code></p><p><code>1472</code><code>              &lt;a class="taxo-term" title="Search for articles about Cancers and neoplasms"</code></p><p><code>1473</code><code>                 href="/plosone/search?filterSubjects=Cancers+and+neoplasms&amp;filterJournals=PLoSONE&amp;q="&gt;Cancers and neoplasms&lt;/a&gt;</code></p><p><code>1474</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1475</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Cancers and neoplasms"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Cancers and neoplasms"&lt;/strong&gt; applicable to this article?</code></p><p><code>1476</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1477</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1478</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1479</code><code>        &lt;/div&gt;</code></p><p><code>1480</code><code>      &lt;/li&gt;</code></p><p><code>1481</code><code>      &lt;li&gt;</code></p><p><code>1482</code><code>              &lt;a class="taxo-term" title="Search for articles about Gene expression"</code></p><p><code>1483</code><code>                 href="/plosone/search?filterSubjects=Gene+expression&amp;filterJournals=PLoSONE&amp;q="&gt;Gene expression&lt;/a&gt;</code></p><p><code>1484</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1485</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Gene expression"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Gene expression"&lt;/strong&gt; applicable to this article?</code></p><p><code>1486</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1487</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1488</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1489</code><code>        &lt;/div&gt;</code></p><p><code>1490</code><code>      &lt;/li&gt;</code></p><p><code>1491</code><code>      &lt;li&gt;</code></p><p><code>1492</code><code>              &lt;a class="taxo-term" title="Search for articles about Metastatic tumors"</code></p><p><code>1493</code><code>                 href="/plosone/search?filterSubjects=Metastatic+tumors&amp;filterJournals=PLoSONE&amp;q="&gt;Metastatic tumors&lt;/a&gt;</code></p><p><code>1494</code><code>        &lt;span class="taxo-flag"&gt;&amp;nbsp;&lt;/span&gt;</code></p><p><code>1495</code><code>        &lt;div class="taxo-tooltip" data-categoryname="Metastatic tumors"&gt;&lt;p class="taxo-explain"&gt;Is the Subject Area &lt;strong&gt;"Metastatic tumors"&lt;/strong&gt; applicable to this article?</code></p><p><code>1496</code><code>          &lt;button id="noFlag" data-action="remove"&gt;Yes&lt;/button&gt;</code></p><p><code>1497</code><code>          &lt;button id="flagIt" value="flagno" data-action="add"&gt;No&lt;/button&gt;&lt;/p&gt;</code></p><p><code>1498</code><code>          &lt;p class="taxo-confirm"&gt;Thanks for your feedback.&lt;/p&gt;</code></p><p><code>1499</code><code>        &lt;/div&gt;</code></p><p><code>1500</code><code>      &lt;/li&gt;</code></p><p><code>1501</code><code>  &lt;/ul&gt;</code></p><p><code>1502</code><code>&lt;/div&gt;</code></p><p><code>1503</code><code>&lt;div id="subjectErrors"&gt;&lt;/div&gt;</code></p><p><code>1504</code><code>  &lt;/aside&gt;</code></p><p><code>1505</code><code>&lt;/div&gt;</code></p><p><code>1506</code><code>          </code></p><p><code>1507</code><code>          </code></p><p><code>1508</code><code>          </code></p><p><code>1509</code><code>          </code></p><p><code>1510</code><code>&lt;/main&gt;</code></p><p><code>1511</code><code>&lt;footer id="pageftr"&gt;</code></p><p><code>1512</code><code>  &lt;div class="row"&gt;</code></p><p><code>1513</code><code>    &lt;div class="block x-small"&gt;</code></p><p><code>1514</code><code>          </code></p><p><code>1515</code><code>&lt;ul class="nav nav-secondary"&gt;</code></p><p><code>1516</code><code>    &lt;li class="ftr-header"&gt;&lt;a href="https://plos.org/publications/journals/"&gt;Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1517</code><code>    &lt;li&gt;&lt;a href="/plosbiology/" id="ftr-bio"&gt;PLOS Biology&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1518</code><code>    &lt;li&gt;&lt;a href="/plosmedicine/" id="ftr-med"&gt;PLOS Medicine&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1519</code><code>    &lt;li&gt;&lt;a href="/ploscompbiol/" id="ftr-compbio"&gt;PLOS Computational Biology&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1520</code><code>    &lt;li&gt;&lt;a href="/plosgenetics/" id="ftr-gen"&gt;PLOS Genetics&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1521</code><code>    &lt;li&gt;&lt;a href="/plospathogens/" id="ftr-path"&gt;PLOS Pathogens&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1522</code><code>    &lt;li&gt;&lt;a href="/plosone/" id="ftr-one"&gt;PLOS ONE&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1523</code><code>    &lt;li&gt;&lt;a href="/plosntds/" id="ftr-ntds"&gt;PLOS Neglected Tropical Diseases&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1524</code><code>  &lt;/ul&gt;</code></p><p><code>1525</code><code>    &lt;/div&gt;</code></p><p><code>1526</code><code>    &lt;div class="block x-small"&gt;</code></p><p><code>1527</code><code>          </code></p><p><code>1528</code><code>&lt;ul class="nav nav-secondary"&gt;</code></p><p><code>1529</code><code>    &lt;li class="ftr-header"&gt;&amp;nbsp;&lt;/li&gt;</code></p><p><code>1530</code><code>    &lt;li&gt;&lt;a href="/climate/" id="ftr-climate"&gt;PLOS Climate&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1531</code><code>    &lt;li&gt;&lt;a href="/digitalhealth/" id="ftr-digitalhealth"&gt;PLOS Digital Health&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1532</code><code>    &lt;li&gt;&lt;a href="/globalpublichealth/" id="ftr-globalpublichealth"&gt;PLOS Global Public Health&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1533</code><code>    &lt;li&gt;&lt;a href="/sustainabilitytransformation/" id="ftr-sustainabilitytransformation"&gt;PLOS Sustainability and Transformation&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1534</code><code>    &lt;li&gt;&lt;a href="/water/" id="ftr-water"&gt;PLOS Water&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1535</code><code>    &lt;li&gt;</code></p><p><code>1536</code><code>      &lt;a href="https://plos.org/complex-systems-research-journal/" id="ftr-complex-systems"&gt;PLOS Complex Systems&lt;/a&gt;</code></p><p><code>1537</code><code>    &lt;/li&gt;</code></p><p><code>1538</code><code>    &lt;li&gt;</code></p><p><code>1539</code><code>      &lt;a href="https://plos.org/mental-health-research-journal/" id="ftr-mental-health"&gt;PLOS Mental Health&lt;/a&gt;</code></p><p><code>1540</code><code>    &lt;/li&gt;</code></p><p><code>1541</code><code>&lt;/ul&gt;</code></p><p><code>1542</code><code>    &lt;/div&gt;</code></p><p><code>1543</code><code>    &lt;div class="block xx-small"&gt;	</code></p><p><code>1544</code><code>          </code></p><p><code>1545</code><code>          </code></p><p><code>1546</code><code>&lt;ul class="nav nav-tertiary"&gt;</code></p><p><code>1547</code><code>  &lt;li&gt;</code></p><p><code>1548</code><code>    &lt;a href="https://plos.org" id="ftr-home"&gt;Home&lt;/a&gt;</code></p><p><code>1549</code><code>  &lt;/li&gt;</code></p><p><code>1550</code><code>  &lt;li&gt;</code></p><p><code>1551</code><code>    &lt;a href="https://blogs.plos.org" id="ftr-blog"&gt;Blogs&lt;/a&gt;</code></p><p><code>1552</code><code>  &lt;/li&gt;</code></p><p><code>1553</code><code>  &lt;li&gt;</code></p><p><code>1554</code><code>    &lt;a href="https://collections.plos.org/" id="ftr-collections"&gt;Collections&lt;/a&gt;</code></p><p><code>1555</code><code>  &lt;/li&gt;</code></p><p><code>1556</code><code>  &lt;li&gt;</code></p><p><code>1557</code><code>    &lt;a href="mailto:webmaster@plos.org" id="ftr-feedback"&gt;Give feedback&lt;/a&gt;</code></p><p><code>1558</code><code>  &lt;/li&gt;</code></p><p><code>1559</code><code>  &lt;li&gt;</code></p><p><code>1560</code><code>    &lt;a href="/plosone/lockss-manifest" id="ftr-lockss"&gt;LOCKSS&lt;/a&gt;</code></p><p><code>1561</code><code>  &lt;/li&gt;</code></p><p><code>1562</code><code>&lt;/ul&gt;</code></p><p><code>1563</code><code>    &lt;/div&gt;</code></p><p><code>1564</code><code>    &lt;div class="block xx-small"&gt;</code></p><p><code>1565</code><code>          </code></p><p><code>1566</code><code>&lt;ul class="nav nav-primary"&gt;</code></p><p><code>1567</code><code>  &lt;li&gt;&lt;a href="https://plos.org/privacy-policy" id="ftr-privacy"&gt;Privacy Policy&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1568</code><code>  &lt;li&gt;&lt;a href="https://plos.org/terms-of-use" id="ftr-terms"&gt;Terms of Use&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1569</code><code>  &lt;li&gt;&lt;a href="https://plos.org/advertise/" id="ftr-advertise"&gt;Advertise&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1570</code><code>  &lt;li&gt;&lt;a href="https://plos.org/media-inquiries" id="ftr-media"&gt;Media Inquiries&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1571</code><code>  &lt;li&gt;&lt;a href="https://plos.org/contact" id="ftr-contact"&gt;Contact&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1572</code><code>&lt;/ul&gt;</code></p><p><code>1573</code><code>    &lt;/div&gt;</code></p><p><code>1574</code><code>  &lt;/div&gt;</code></p><p><code>1575</code><code>  &lt;div class="row"&gt;</code></p><p><code>1576</code><code>    &lt;p&gt;</code></p><p><code>1577</code><code>          </code></p><p><code>1578</code><code>&lt;img src="/resource/img/logo-plos-footer.png" alt="PLOS" class="logo-footer"/&gt;</code></p><p><code>1579</code><code>          </code></p><p><code>1580</code><code>          </code></p><p><code>1581</code><code>&lt;span class="footer-non-profit-statement"&gt;PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US&lt;/span&gt;    &lt;/p&gt;</code></p><p><code>1582</code><code>    &lt;div class="block"&gt;</code></p><p><code>1583</code><code>    &lt;/div&gt;</code></p><p><code>1584</code><code>  &lt;/div&gt;</code></p><p><code>1585</code><code> </code></p><p><code>1586</code><code>&lt;script src="/resource/js/global.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1587</code><code>&lt;/footer&gt;</code></p><p><code>1588</code><code>          </code></p><p><code>1589</code><code>          </code></p><p><code>1590</code><code>          </code></p><p><code>1591</code><code>          </code></p><p><code>1592</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>1593</code><code>  var ArticleData = {</code></p><p><code>1594</code><code>    doi: '10.1371/journal.pone.0035569',</code></p><p><code>1595</code><code>    title: '&lt;article-title xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer&lt;\/article-title&gt;',</code></p><p><code>1596</code><code>    date: 'Apr 18, 2012'</code></p><p><code>1597</code><code>  };</code></p><p><code>1598</code><code>&lt;/script&gt;</code></p><p><code>1599</code><code>&lt;script src="/resource/js/components/show_onscroll.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1600</code><code>&lt;script src="/resource/js/components/pagination.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1601</code><code>&lt;script src="/resource/js/vendor/spin.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1602</code><code>&lt;script src="/resource/js/pages/article.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1603</code><code>&lt;script src="/resource/js/pages/article_references.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1604</code><code>&lt;script src="/resource/js/pages/article_sidebar.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1605</code><code>&lt;script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1606</code><code>  &lt;script src="/resource/js/components/table_open.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1607</code><code>          </code></p><p><code>1608</code><code>        &lt;script src="/resource/js/components/figshare.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1609</code><code>  &lt;script src="/resource/js/vendor/jquery.panzoom.min.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1610</code><code>  &lt;script src="/resource/js/vendor/jquery.mousewheel.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1611</code><code>          </code></p><p><code>1612</code><code>  &lt;script src="/resource/js/components/lightbox.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1613</code><code>          </code></p><p><code>1614</code><code>  &lt;script src="/resource/js/pages/article_body.js" type="text/javascript"&gt;&lt;/script&gt;</code></p><p><code>1615</code><code>          </code></p><p><code>1616</code><code>          </code></p><p><code>1617</code><code>&lt;!-- This file should be loaded before the renderJs, to avoid conflicts with the FigShare, that implements the MathJax also. --&gt;</code></p><p><code>1618</code><code>          </code></p><p><code>1619</code><code>&lt;!--  mathjax configuration options  --&gt;</code></p><p><code>1620</code><code>&lt;!-- more can be found at http://docs.mathjax.org/en/latest/ --&gt;</code></p><p><code>1621</code><code>&lt;script type="text/x-mathjax-config"&gt;</code></p><p><code>1622</code><code>MathJax.Hub.Config({</code></p><p><code>1623</code><code>  "HTML-CSS": {</code></p><p><code>1624</code><code>    scale: 100,</code></p><p><code>1625</code><code>    availableFonts: ["STIX","TeX"],</code></p><p><code>1626</code><code>    preferredFont: "STIX",</code></p><p><code>1627</code><code>    webFont: "STIX-Web",</code></p><p><code>1628</code><code>    linebreaks: { automatic: false }</code></p><p><code>1629</code><code>  },</code></p><p><code>1630</code><code>  jax: ["input/MathML", "output/HTML-CSS"]</code></p><p><code>1631</code><code>});</code></p><p><code>1632</code><code>&lt;/script&gt;</code></p><p><code>1633</code><code>          </code></p><p><code>1634</code><code>&lt;script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=MML_HTMLorMML"&gt;&lt;/script&gt;</code></p><p><code>1635</code><code>          </code></p><p><code>1636</code><code>&lt;div class="reveal-modal-bg"&gt;&lt;/div&gt;</code></p><p><code>1637</code><code>&lt;/body&gt;</code></p><p><code>1638</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>